価格表

在庫・価格 : 2025年04月26日 19時27分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Survivin, Rabbit-Poly
データシート
NB500-201 NOVノバス バイオロジカルス
Novus biologicals, LLC
0.1 ml ¥96,000
(未発注)
追加

在庫・価格 : 2025年04月26日 19時27分 現在

Anti-Survivin, Rabbit-Poly

  • 商品コード:NB500-201
  • メーカー:NOV
  • 包装:0.1ml
  • 価格: ¥96,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 de Minzi MC et al. Effect of inapplicable items in the factor structure of the Spanish version of the Ways of Coping Questionnaire. Psychol Rep 2001 Feb;88(1):115-22
de Minzi MC et al
2001/01/01
PubMed
2 Wheatley SP et al. INCENP is required for proper targeting of Survivin to the centromeres and the anaphase spindle during mitosis. Curr. Biol. 2001 Jun;11(11):886-90
Wheatley SP et al
2001/01/01
Species: Human, Applications: ICC/IF PubMed
3 Zhu L et al. Anti-apoptotic protein survivin plays a significant role in tubular morphogenesis of human coronary arteriolar endothelial cells by hypoxic preconditioning. FEBS Lett. 2001 Nov;508(3):369-74
Zhu L et al
2001/01/01
PubMed
4 Chakravarti A et al. Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J. Clin. Oncol. 2002 Feb;20(4):1063-8
Chakravarti A et al
2002/01/01
Species: Human, Applications: WB PubMed
5 Fortugno P et al. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J. Cell. Sci. 2002 Feb;115(Pt 3):575-85
Fortugno P et al
2002/01/01
Species: Human, Applications: IP, WB, ICC/IF PubMed
6 Giodini A et al. Regulation of microtubule stability and mitotic progression by survivin. Cancer Res. 2002 May;62(9):2462-7
Giodini A et al
2002/01/01
Species: Human PubMed
7 Zhang C et al. Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. Clin. Cancer Res. 2002 May;8(5):1234-40
Zhang C et al
2002/01/01
PubMed
8 Qanungo S et al. 2-Methoxyestradiol induces mitochondria dependent apoptotic signaling in pancreatic cancer cells. Oncogene 2002 Jun;21(26):4149-57
Qanungo S et al
2002/01/01
PubMed
9 Yu J et al. Increased expression of survivin in gastric cancer patients and in first degree relatives. Br. J. Cancer 2002 Jul;87(1):91-7
Yu J et al
2002/01/01
Species: Human, Applications: WB, IHC-P PubMed
10 O'Connor DS et al. A p34(cdc2) survival checkpoint in cancer. Cancer Cell 2002 Jul;2(1):43-54
O'Connor DS et al
2002/01/01
Species: Human, Applications: WB, IP PubMed
11 Blanc-Brude OP et al. Inhibitor of apoptosis protein survivin regulates vascular injury. Nat. Med. 2002 Sep;8(9):987-94
Blanc-Brude OP et al
2002/01/01
Species: Rat, Applications: WB, IHC-Fr, ICC/IF PubMed
12 Mahotka C et al. Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ. 2002 Dec;9(12):1334-42
Mahotka C et al
2002/01/01
PubMed
13 Faderl S et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia. Blood 2003 Jul;102(2):630-7
Faderl S et al
2003/01/01
PubMed
14 Kennedy SM et al. Prognostic importance of survivin in breast cancer. Br. J. Cancer 2003 Apr;88(7):1077-83
Kennedy SM et al
2003/01/01
Species: Human, Applications: IHC-Fr, IHC-P PubMed
15 Hauf S et al. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J. Cell Biol. 2003 Apr;161(2):281-94
Hauf S et al
2003/01/01
PubMed
16 Ramp U et al. Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage. Br. J. Cancer 2003 Jun;88(11):1800-7
Ramp U et al
2003/01/01
PubMed
17 Carvalho A et al. Survivin is required for stable checkpoint activation in taxol-treated HeLa cells. J. Cell. Sci. 2003 Jul;116(Pt 14):2987-98
Carvalho A et al
2003/01/01
PubMed
18 Blanc-Brude OP et al. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin. Cancer Res. 2003 Jul;9(7):2683-92
Blanc-Brude OP et al
2003/01/01
PubMed
19 Chen Y et al. Loss of inhibitor of apoptosis proteins as a determinant of polyamine analog-induced apoptosis in human melanoma cells. Oncogene 2003 Aug;22(32):4964-72
Chen Y et al
2003/01/01
PubMed
20 Honda R et al. Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis. Mol. Biol. Cell 2003 Aug;14(8):3325-41
Honda R et al
2003/01/01
PubMed
21 Neef R et al. Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis. J. Cell Biol. 2003 Sep;162(5):863-75
Neef R et al
2003/01/01
PubMed
22 Fornaro M et al. Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway. J. Biol. Chem. 2003 Dec;278(50):50402-11
Fornaro M et al
2003/01/01
PubMed
23 Beltrami E et al. Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis. J. Biol. Chem. 2004 Jan;279(3):2077-84
Beltrami E et al
2004/01/01
PubMed
24 Altura RA et al. Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade. Br. J. Cancer 2003 Nov;89(9):1743-9
Altura RA et al
2003/01/01
PubMed
25 Krysan K et al. COX-2-dependent stabilization of survivin in non-small cell lung cancer. FASEB J. 2004 Jan;18(1):206-8
Krysan K et al
2004/01/01
PubMed
26 Fortugno P et al. Regulation of survivin function by Hsp90. Proc. Natl. Acad. Sci. U.S.A. 2003 Nov;100(24):13791-6
Fortugno P et al
2003/01/01
PubMed
27 Chen JG et al. Gene expression and mitotic exit induced by microtubule-stabilizing drugs. Cancer Res. 2003 Nov;63(22):7891-9
Chen JG et al
2003/01/01
PubMed
28 Lo Muzio L et al. Survivin expression in oral squamous cell carcinoma. Br. J. Cancer 2003 Dec;89(12):2244-8
Lo Muzio L et al
2003/01/01
PubMed
29 Liu T et al. Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells. Oncogene 2004 Jan;23(1):39-48
Liu T et al
2004/01/01
PubMed
30 Kirkiles-Smith NC et al. IL-11 protects human microvascular endothelium from alloinjury in vivo by induction of survivin expression. J. Immunol. 2004 Feb;172(3):1391-6
Kirkiles-Smith NC et al
2004/01/01
PubMed
31 Martinez A et al. Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival. Am. J. Pathol. 2004 Feb;164(2):501-10
Martinez A et al
2004/01/01
PubMed
32 Zha H et al. Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray. Lab. Invest. 2004 Feb;84(2):235-44
Zha H et al
2004/01/01
PubMed
33 Asanuma K et al. Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells. J. Immunol. 2004 Mar;172(6):3922-9
Asanuma K et al
2004/01/01
PubMed
34 Johnson VL et al. Bub1 is required for kinetochore localization of BubR1, Cenp-E, Cenp-F and Mad2, and chromosome congression. J. Cell. Sci. 2004 Mar;117(Pt 8):1577-89
Johnson VL et al
2004/01/01
PubMed
35 Schlette EJ et al. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. J. Clin. Oncol. 2004 May;22(9):1682-8
Schlette EJ et al
2004/01/01
PubMed
36 Geddis AE et al. Megakaryocytes express functional Aurora-B kinase in endomitosis. Blood 2004 Aug;104(4):1017-24
Geddis AE et al
2004/01/01
Species: Mouse, Human, Applications: ICC/IF PubMed
37 Gassmann R et al. Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle. J. Cell Biol. 2004 Jul;166(2):179-91
Gassmann R et al
2004/01/01
PubMed
38 Chakravarti A et al. Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. Oncogene 2004 Sep;23(45):7494-506
Chakravarti A et al
2004/01/01
PubMed
39 Mallikarjuna G et al. Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling. Cancer Res. 2004 Sep;64(17):6349-56
Mallikarjuna G et al
2004/01/01
PubMed
40 Chen JS et al. Cancer-specific activation of the survivin promoter and its potential use in gene therapy. Cancer Gene Ther. 2004 Nov;11(11):740-7
Chen JS et al
2004/01/01
PubMed
41 Krysan K et al. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer. Cancer Res. 2004 Sep;64(18):6359-62
Krysan K et al
2004/01/01
PubMed
42 Ferrer A et al. Activation of mitochondrial apoptotic pathway in mantle cell lymphoma: high sensitivity to mitoxantrone in cases with functional DNA-damage response genes. Oncogene 2004 Nov;23(55):8941-9
Ferrer A et al
2004/01/01
PubMed
43 Scrittori L et al. A small C-terminal sequence of Aurora B is responsible for localization and function. Mol. Biol. Cell 2005 Jan;16(1):292-305
Scrittori L et al
2005/01/01
Species: Human, Applications: ICC/IF, WB PubMed
44 Vischioni B et al. Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer. Ann. Oncol. 2004 Nov;15(11):1654-60
Vischioni B et al
2004/01/01
PubMed
45 MacCallum DE et al. Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1. Cancer Res. 2005 Jun;65(12):5399-407
MacCallum DE et al
2005/01/01
PubMed
46 Pennati M et al. Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation. Mol. Cancer Ther. 2005 Sep;4(9):1328-37
Pennati M et al
2005/01/01
PubMed
47 Hata T et al. Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells. Mol. Cancer Ther. 2005 Oct;4(10):1585-94
Hata T et al
2005/01/01
PubMed
48 Kim EY et al. TNF receptor type 2 (p75) functions as a costimulator for antigen-driven T cell responses in vivo. J. Immunol. 2006 Jan;176(2):1026-35
Kim EY et al
2006/01/01
Species: Mouse, Applications: FLOW, ICC/IF PubMed
49 Mao JT et al. Celecoxib decreases Ki-67 proliferative index in active smokers. Clin. Cancer Res. 2006 Jan;12(1):314-20
Mao JT et al
2006/01/01
PubMed
50 Farheen S et al. Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene. World J. Gastroenterol. 2006 Apr;12(14):2269-75
Farheen S et al
2006/01/01
PubMed
51 Fukuda S et al. Survivin, a cancer target with an emerging role in normal adult tissues. Mol. Cancer Ther. 2006 May;5(5):1087-98
Fukuda S et al
2006/01/01
PubMed
52 Kang BH et al. Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein. J. Biol. Chem. 2006 Aug;281(34):24721-7
Kang BH et al
2006/01/01
PubMed
53 Hahn JY et al. Beta-catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts. J. Biol. Chem. 2006 Oct;281(41):30979-89
Hahn JY et al
2006/01/01
PubMed
54 Yip KW et al. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Clin. Cancer Res. 2006 Oct;12(19):5726-32
Yip KW et al
2006/01/01
Species: Human, Applications: IHC-P PubMed
55 Caldas H et al. Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis. Blood 2007 Feb;109(4):1479-89
Caldas H et al
2007/01/01
PubMed
56 Deep G et al. Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells. Carcinogenesis 2007 Jul;28(7):1533-42
Deep G et al
2007/01/01
PubMed
57 Huang H et al. Tripin/hSgo2 recruits MCAK to the inner centromere to correct defective kinetochore attachments. J. Cell Biol. 2007 May;177(3):413-24
Huang H et al
2007/01/01
PubMed
58 Gong J et al. Attenuation of apoptosis by chromogranin A-induced Akt and survivin pathways in prostate cancer cells. Endocrinology 2007 Sep;148(9):4489-99
Gong J et al
2007/01/01
PubMed
59 Kindt N et al. Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced acute renal failure. FASEB J. 2008 Feb;22(2):510-21
Kindt N et al
2008/01/01
PubMed
60 Niedbala W et al. Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25 T cells via p53, IL-2, and OX40. Proc. Natl. Acad. Sci. U.S.A. 2007 Sep;104(39):15478-83
Niedbala W et al
2007/01/01
Species: Mouse, Applications: FLOW PubMed
61 Lechler P et al. The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney. Am. J. Pathol. 2007 Nov;171(5):1483-98
Lechler P et al
2007/01/01
Species: Human, Rat, Mouse, Applications: IHC-P PubMed
62 Moiseeva EP et al. Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells. Mol. Cancer Ther. 2007 Nov;6(11):3071-9
Moiseeva EP et al
2007/01/01
PubMed
63 Skoufias DA et al. Mitosis persists in the absence of Cdk1 activity when proteolysis or protein phosphatase activity is suppressed. J. Cell Biol. 2007 Nov;179(4):671-85
Skoufias DA et al
2007/01/01
PubMed
64 Connell CM et al. Nuclear survivin has reduced stability and is not cytoprotective. J. Biol. Chem. 2008 Feb;283(6):3289-96
Connell CM et al
2008/01/01
ImmunoPrecipitation PubMed
65 Ghosh JC et al. Hsp60 regulation of tumor cell apoptosis. J. Biol. Chem. 2008 Feb;283(8):5188-94
Ghosh JC et al
2008/01/01
PubMed
66 Tyagi A et al. Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice. Mol. Cancer Ther. 2007 Dec;6(12 Pt 1):3248-55
Tyagi A et al
2007/01/01
PubMed
67 Singh RP et al. Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin. Clin. Cancer Res. 2008 Jan;14(1):300-8
Singh RP et al
2008/01/01
PubMed
68 Niibe Y et al. Concomitant expression of HER2 and HIF-1alpha is a predictor of poor prognosis in uterine cervical carcinoma treated with concurrent chemoradiotherapy: prospective analysis (KGROG0501). Eur. J. Gynaecol. Oncol. 2010;31(5):491-6
Niibe Y et al
2010/01/01
PubMed
69 AbouAlaiwi WA et al. Endothelial cells from humans and mice with polycystic kidney disease are characterized by polyploidy and chromosome segregation defects through survivin down-regulation. Hum. Mol. Genet. 2011 Jan;20(2):354-67
AbouAlaiwi WA et al
2011/01/01
Species: Mouse, Applications: WB PubMed
70 Asanuma H et al. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Res. 2005 Dec;65(23):
Asanuma H et al
2005/01/01
PubMed
71 Thirunavukkarasu M et al. Adeno-sh-beta-catenin abolishes ischemic preconditioning-mediated cardioprotection by downregulation of its target genes VEGF, Bcl-2, and survivin in ischemic rat myocardium. Antioxid. Redox Signal. 2008 Aug;10(8):1475-84
Thirunavukkarasu M et al
2008/01/01
PubMed
72 Fossey SL et al. The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines. BMC Cancer 2011;11:112
Fossey SL et al
2011/01/01
Species: Human, Canine, Applications: WB PubMed
73 Lou Y et al. Oral administration of caffeine during voluntary exercise markedly decreases tissue fat and stimulates apoptosis and cyclin B1 in UVB-treated skin of hairless p53-knockout mice. Carcinogenesis 2010 Apr;31(4):671-8
Lou Y et al
2010/01/01
PubMed
74 Miranda MB et al. Differential activation of apoptosis regulatory pathways during monocytic vs granulocytic differentiation: a requirement for Bcl-X(L)and XIAP in the prolonged survival of monocytic cells. Leukemia 2003 Feb;17(2):390-400
Miranda MB et al
2003/01/01
PubMed
75 Finkelstein SE et al. Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients. Int. J. Radiat. Oncol. Biol. Phys. 2012 Feb;82(2):924-32
Finkelstein SE et al
2012/01/01
PubMed
76 Chiou SK et al. Sulindac sulfide induces autophagic death in gastric epithelial cells via survivin down-regulation: a mechanism of NSAIDs-induced gastric injury. Biochem. Pharmacol. 2011 Jun;81(11):1317-23
Chiou SK et al
2011/01/01
PubMed
77 Robles AI et al. Schedule-dependent synergy between the heat shock protein 90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin and doxorubicin restores apoptosis to p53-mutant lymphoma cell lines. Clin. Cancer Res. 2006 Nov;12(21):6547-56
Robles AI et al
2006/01/01
PubMed
78 Lubet RA et al. 4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin. Carcinogenesis 2005 Mar;26(3):571-8
Lubet RA et al
2005/01/01
Species: Mouse, Applications: IHC-P PubMed
79 El Ghamrasni S et al. Inactivation of chk2 and mus81 leads to impaired lymphocytes development, reduced genomic instability, and suppression of cancer. PLoS Genet. 2011 May;7(5):e1001385
El Ghamrasni S et al
2011/01/01
PubMed
80 Zhang L et al. Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 2008 Dec;105(49):19532-7
Zhang L et al
2008/01/01
PubMed
81 Felisiak-Golabek A et al. Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients. J Ovarian Res 2011;4(1):20
Felisiak-Golabek A et al
2011/01/01
PubMed
82 Hebb AL et al. Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination. Mult. Scler. 2008 Jun;14(5):577-94
Hebb AL et al
2008/01/01
PubMed
83 Lechler P et al. The antiapoptotic gene survivin is highly expressed in human chondrosarcoma and promotes drug resistance in chondrosarcoma cells in vitro. BMC Cancer 2011;11:120
Lechler P et al
2011/01/01
PubMed
84 Jacob NK et al. Survivin splice variants are not essential for mitotic progression or inhibition of apoptosis induced by doxorubicin and radiation. Onco Targets Ther 2012;5:7-20
Jacob NK et al
2012/01/01
Species: Human, Applications: WB PubMed
85 Seo SI et al. BKM1740, an acyl-tyrosine bisphosphonate amide derivative, inhibits the bone metastatic growth of human prostate cancer cells by inducing apoptosis. Clin. Cancer Res. 2008 Oct;14(19):6198-206
Seo SI et al
2008/01/01
PubMed
86 Kim SH et al. Garlic constituent diallyl trisulfide suppresses x-linked inhibitor of apoptosis protein in prostate cancer cells in culture and in vivo. Cancer Prev Res (Phila) 2011 Jun;4(6):897-906
Kim SH et al
2011/01/01
Species: Human, Mouse, Applications: WB, IHC PubMed
87 Francisco R et al. Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells. Cancer Lett. 2012 May;318(1):42-52
Francisco R et al
2012/01/01
Species: Human, Applications: WB PubMed
88 Lechler P et al. The oncofetal gene survivin is re-expressed in osteoarthritis and is required for chondrocyte proliferation in vitro. BMC Musculoskelet Disord 2011;12:150
Lechler P et al
2011/01/01
PubMed
89 Shariat SF et al. Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study. Clin. Cancer Res. 2009 Nov;15(22):7012-9
Shariat SF et al
2009/01/01
PubMed
90 Eberhard Y et al. Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells. Blood 2009 Oct;114(14):3064-73
Eberhard Y et al
2009/01/01
PubMed
91 Lee JH et al. Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation. Am. J. Physiol., Cell Physiol. 2009 Feb;296(2):C327-38
Lee JH et al
2009/01/01
PubMed
92 Adler M et al. Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity. Carcinogenesis 2009 Apr;30(4):711-9
Adler M et al
2009/01/01
Species: Rat, Applications: IHC-P PubMed
93 Talbot DC et al. Tumor survivin is downregulated by the antisense oligonucleotide LY2181308: a proof-of-concept, first-in-human dose study. Clin. Cancer Res. 2010 Dec;16(24):6150-8
Talbot DC et al
2010/01/01
PubMed
94 Lu J et al. Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistance. Clin. Cancer Res. 2009 Feb;15(4):1326-34
Lu J et al
2009/01/01
PubMed
95 Xu Y et al. A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol. 2004 Sep;23(9):527-37
Xu Y et al
2004/01/01
PubMed
96 Song KY et al. Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma. Jpn. J. Clin. Oncol. 2009 May;39(5):290-6
Song KY et al
2009/01/01
PubMed
97 Kavitha CV et al. Asiatic acid inhibits pro-angiogenic effects of VEGF and human gliomas in endothelial cell culture models. PLoS ONE 2011;6(8):e22745
Kavitha CV et al
2011/01/01
PubMed
98 Zeitlin SG et al. CENP-A is phosphorylated by Aurora B kinase and plays an unexpected role in completion of cytokinesis. J. Cell Biol. 2001 Dec;155(7):1147-57
Zeitlin SG et al
2001/01/01
Species: Human, Applications: WB, ICC/IF PubMed
99 Lee CW et al. Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. Cancer Res. 2008 Jul;68(13):5273-81
Lee CW et al
2008/01/01
PubMed
100 Borghouts C et al. Monomeric recombinant peptide aptamers are required for efficient intracellular uptake and target inhibition. Mol. Cancer Res. 2008 Feb;6(2):267-81
Borghouts C et al
2008/01/01
PubMed
101 Kim EY et al. TNFR2-deficient memory CD8 T cells provide superior protection against tumor cell growth. J. Immunol. 2009 Nov;183(10):6051-7
Kim EY et al
2009/01/01
PubMed
102 Amin HM et al. Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma. Oncogene 2004 Jul;23(32):5426-34
Amin HM et al
2004/01/01
PubMed
103 Symes JC et al. Fas-mediated killing of primary prostate cancer cells is increased by mitoxantrone and docetaxel. Mol. Cancer Ther. 2008 Sep;7(9):3018-28
Symes JC et al
2008/01/01
PubMed
104 Dai Y et al. Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis. Clin. Cancer Res. 2008 Dec;14(23):7701-10
Dai Y et al
2008/01/01
PubMed
105 Komuro Y et al. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis. Mod. Pathol. 2004 Feb;17(2):264
Komuro Y et al
2004/01/01
PubMed
106 Guha M et al. Endogenous tumor suppression mediated by PTEN involves survivin gene silencing. Cancer Res. 2009 Jun;69(12):4954-8
Guha M et al
2009/01/01
PubMed
107 Engels K et al. NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas. Cancer Res. 2008 Jul;68(13):5159-66
Engels K et al
2008/01/01
PubMed
108 Xia F et al. A survivin-ran complex regulates spindle formation in tumor cells. Mol. Cell. Biol. 2008 Sep;28(17):5299-311
Xia F et al
2008/01/01
PubMed
109 Rudkowski JC et al. Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis. Am. J. Physiol. Lung Cell Mol. Physiol. 2004 Apr;286(4):L793-800
Rudkowski JC et al
2004/01/01
Species: Rat, Applications: WB PubMed
110 Xia M et al. p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation. Oncogene 2011 Jan;30(3):346-55
Xia M et al
2011/01/01
PubMed
111 Schaue D et al. T-cell responses to survivin in cancer patients undergoing radiation therapy. Clin. Cancer Res. 2008 Aug;14(15):4883-90
Schaue D et al
2008/01/01
PubMed
112 Gould Rothberg BE et al. Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis. J. Natl. Cancer Inst. 2009 Apr;101(7):452-74
Gould Rothberg BE et al
2009/01/01
PubMed
113 Grabowski P et al. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br. J. Cancer 2003 Jan;88(1):115-9
Grabowski P et al
2003/01/01
PubMed
114 Khan S et al. Survivin is released from cancer cells via exosomes. Apoptosis 2011 Jan;16(1):1-12
Khan S et al
2011/01/01
PubMed
115 Jiang X et al. Imatinib targeting of KIT-mutant oncoprotein in melanoma. Clin. Cancer Res. 2008 Dec;14(23):7726-32
Jiang X et al
2008/01/01
PubMed
116 Xia F et al. Tumor cell dependence on Ran-GTP-directed mitosis. Cancer Res. 2008 Mar;68(6):1826-33
Xia F et al
2008/01/01
PubMed
117 Chun KS et al. The prostaglandin E2 receptor, EP2, regulates survivin expression via an EGFR/STAT3 pathway in UVB-exposed mouse skin. Mol. Carcinog. 2011 Jun;50(6):439-48
Chun KS et al
2011/01/01
Species: Mouse, Applications: WB PubMed
118 Chen B et al. Rapamycin decreases survivin expression to induce NSCLC cell apoptosis under hypoxia through inhibiting HIF-1α induction. Mol. Biol. Rep. 2012 Jan;39(1):185-91
Chen B et al
2012/01/01
Species: Human, Applications: WB PubMed
119 Lechler P et al. The oncofetal gene survivin promotes cell proliferation and survival in primary human osteoblastic cells. Calcif. Tissue Int. 2011 Sep;89(3):211-20
Lechler P et al
2011/01/01
Species: Human, Applications: ICC/IF PubMed
120 Page BD et al. Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain. Bioorg. Med. Chem. Lett. 2011 Sep;21(18):5605-9
Page BD et al
2011/01/01
PubMed
121 Saxena P et al. PSA regulates androgen receptor expression in prostate cancer cells. Prostate 2012 May;72(7):769-76
Saxena P et al
2012/01/01
Species: Human, Applications: WB PubMed
122 D鱈az A et al. Pigmented spindle cell nevus: clues for differentiating it from spindle cell malignant melanoma. A comprehensive survey including clinicopathologic, immunohistochemical, and FISH studies. Am. J. Surg. Pathol. 2011 Nov;35(11):1733-42
D鱈az A et al
2011/01/01
Species: Human, Applications: IHC PubMed
123 Yakirevich E et al. Total Survivin and acetylated Survivin correlate with distinct molecular subtypes of breast cancer. Hum. Pathol. 2012 Jun;43(6):865-73
Yakirevich E et al
2012/01/01
Species: Human, Applications: IHC PubMed
124 Dhawan D et al. DNMT1: An emerging target in the treatment of invasive urinary bladder cancer. Urol Oncol 2012 May;
Dhawan D et al
2012/01/01
Species: canine, Applications: WB PubMed
125 de Souza HS et al. Increased Levels of Survivin, via Association With Heat Shock Protein 90, in Mucosal T Cells From Patients With Crohn's Disease. Gastroenterology 2012 Oct;143(4):1017-1026.e9
de Souza HS et al
2012/01/01
Species: Human, Applications: IHC, ICC/IF, IP PubMed
126 . ;

Species: Human, Applications: WB PubMed
127 Chao C et al. Epstein-Barr Virus Infection and Expression of B-cell Oncogenic Markers in HIV-Related Diffuse Large B-cell Lymphoma. Clin. Cancer Res. 2012 Sep;18(17):4702-4712
Chao C et al
2012/01/01
Species: Human, Applications: IHC PubMed
128 Bongiovanni L et al. Nuclear survivin expression as a potentially useful tool for the diagnosis of canine cutaneous sebaceous lesions. Vet. Dermatol. 2012 Oct;23(5):394-e73
Bongiovanni L et al
2012/01/01
Species: Canine, Applications: IHC PubMed
129 Jiang C et al. Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion. World J. Gastroenterol. 2012 Jun;18(23):2956-65
Jiang C et al
2012/01/01
Species: Human, Applications: WB PubMed
130 Ebata A et al. Oestrogen-induced genes in ductal carcinoma in situ: their comparison with invasive ductal carcinoma. Endocr. Relat. Cancer 2012 Aug;19(4):485-96
Ebata A et al
2012/01/01
Species: Human, Applications: IHC PubMed
131 Velummailum R. Involvement of NLRP5 in the maintenance of genome integrity in murine oocytes [Internet]. 2011.

PubMed
132 Bongiovanni L et al. Immunohistochemical investigation of cell cycle and apoptosis regulators (Survivin, β-Catenin, P53, Caspase 3) in canine appendicular osteosarcoma. BMC Vet. Res. 2012;8:78
Bongiovanni L et al
2012/01/01
Species: Canine, Applications: IHC PubMed
133 Jia L et al. ROC1/RBX1 E3 ubiquitin ligase silencing suppresses tumor cell growth via sequential induction of G2-M arrest, apoptosis, and senescence. Cancer Res. 2009 Jun;69(12):4974-82
Jia L et al
2009/01/01
Applications: WB PubMed
134 Min L et al. Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat. Cell Biol. 2012 Nov;14(11):1203-11
Min L et al
2012/01/01
Species: Human, Applications: IHC PubMed
135 Wang F et al. Haspin inhibitors reveal centromeric functions of Aurora B in chromosome segregation. J. Cell Biol. 2012 Oct;199(2):251-68
Wang F et al
2012/01/01
PubMed
136 Erba HP et al. Safety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia (AML). Invest New Drugs 2013 Feb;
Erba HP et al
2013/01/01
Species: Human, Applications: ELISA PubMed
137 Kan CY et al. Upregulation of survivin during immortalization of human myofibroblasts is linked to repression of tumor suppressor p16INK4a and confers resistance to oxidative stress. J. Biol. Chem. 2013 Feb;
Kan CY et al
2013/01/01
Species: Human, Applications: WB PubMed
138 D鱈az R et al. Differential regulation of TP73 isoforms by 1α,25-dihydroxyvitamin D3 and survivin in human colon and breast carcinomas. Genes Chromosomes Cancer 2010 Dec;49(12):1135-42
D鱈az R et al
2010/01/01
Species: Human, Applications: WB PubMed
139 Hori M et al. The detergent-soluble cytoplasmic pool of survivin suppresses anoikis and its expression is associated with metastatic disease of human colon cancer. PLoS ONE 2013;8(2):e55710
Hori M et al
2013/01/01
Species: Human, Hamster, Applications: WB PubMed
140 Bongiovanni L et al. Epithelial-to-mesenchymal transition: immunohistochemical investigation of related molecules in canine cutaneous epithelial tumours. Vet. Dermatol. 2013 Feb;24(1):195-203.e42-3
Bongiovanni L et al
2013/01/01
Species: Canine, Applications: IHC-P PubMed
141 Knauer SK et al. Functional characterization of novel mutations affecting survivin (BIRC5)-mediated therapy resistance in head and neck cancer patients. Hum. Mutat. 2013 Feb;34(2):395-404
Knauer SK et al
2013/01/01
Species: Human, Applications: IHC PubMed
142 Sun Y et al. Inhibition of STAT signalling in bladder cancer by diindolylmethane: relevance to cell adhesion, migration and proliferation. Curr Cancer Drug Targets 2013 Jan;13(1):57-68
Sun Y et al
2013/01/01
Species: Human, Applications: WB PubMed
143 Dallaglio K et al. E-FABP induces differentiation in normal human keratinocytes and modulates the differentiation process in psoriatic keratinocytes in vitro. Exp. Dermatol. 2013 Apr;22(4):255-61
Dallaglio K et al
2013/01/01
PubMed
144 Gnana-Prakasam JP et al. Loss of Hfe leads to progression of tumor phenotype in primary retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 2013 Jan;54(1):63-71
Gnana-Prakasam JP et al
2013/01/01
PubMed
145 Chiou SK et al. Nutrient availability alters the effect of autophagy on sulindac sulfide-induced colon cancer cell apoptosis. Gastroenterol Res Pract 2012;2012:897678
Chiou SK et al
2012/01/01
Species: Human, Applications: WB PubMed
146 R端ckert F et al. Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis. BMC Cancer 2010;10:379
R端ckert F et al
2010/01/01
Species: Human, Applications: WB PubMed
147 Goel HL et al. β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase1. J. Cell. Physiol. 2013 Jan;
Goel HL et al
2013/01/01
Species: Human, Applications: WB PubMed
148 Cheng CW et al. PIN1 inhibits apoptosis in hepatocellular carcinoma through modulation of the antiapoptotic function of survivin. Am. J. Pathol. 2013 Mar;182(3):765-75
Cheng CW et al
2013/01/01
PubMed
149 Chock KL et al. BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells. Cancer Res. 2010 Nov;70(21):8782-91
Chock KL et al
2010/01/01
Species: Human, Applications: WB PubMed
150 Knauer SK et al. An otoprotective role for the apoptosis inhibitor protein survivin. Cell Death Dis 2010;1:e51
Knauer SK et al
2010/01/01
Species: Guinea Pig, Applications: IHC-P PubMed
151 Wimmershoff J et al. Immunohistochemical detection of survivin in canine lymphoma. J. Comp. Pathol. 2010 May;142(4):311-22
Wimmershoff J et al
2010/01/01
Species: Canine, Applications: IHC PubMed
152 Tecleab A et al. Depletion of K-Ras promotes proteasome degradation of survivin. Cell Cycle 2013 Feb;12(3):522-32
Tecleab A et al
2013/01/01
Species: Human, Applications: IP PubMed
153 Baba HA et al. Survivin is upregulated during liver regeneration in rats and humans and is associated with hepatocyte proliferation. Liver Int. 2009 Apr;29(4):585-92
Baba HA et al
2009/01/01
Species: Rat, Applications: IHC-P, WB PubMed
154 Svec J et al. Enhanced expression of proproliferative and antiapoptotic genes in ulcerative colitis-associated neoplasia. Inflamm. Bowel Dis. 2010 Jul;16(7):1127-37
Svec J et al
2010/01/01
Species: Human, Applications: IHC PubMed
155 Kabbarah O et al. Integrative genome comparison of primary and metastatic melanomas. PLoS ONE 2010;5(5):e10770
Kabbarah O et al
2010/01/01
Species: Human, Applications: IHC PubMed
156 Honegger A et al. Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells. Int. J. Cancer 2013 Oct;133(7):1631-42
Honegger A et al
2013/01/01
Species: Human, Applications: WB PubMed
157 Tyagi A et al. Differential effect of grape seed extract against human non-small-cell lung cancer cells: the role of reactive oxygen species and apoptosis induction. Nutr Cancer 2013;65 Suppl 1:44-53
Tyagi A et al
2013/01/01
Species: Human, Applications: WB PubMed
158 Appleyard MV et al. Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model. Int. J. Cancer 2009 Jan;124(2):465-72
Appleyard MV et al
2009/01/01
Species: Human, Applications: IHC-P PubMed
159 Slagter-J辰ger JG et al. Evaluation of RNA Amplification Methods to Improve DC Immunotherapy Antigen Presentation and Immune Response. Mol Ther Nucleic Acids 2013;2:e91
Slagter-J辰ger JG et al
2013/01/01
Species: Human, Applications: WB PubMed
160 Augello C et al. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma. BMC Cancer 2009;9:125
Augello C et al
2009/01/01
Species: Human, Applications: IHC PubMed
161 Fetz V et al. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin. Int. J. Cancer 2009 May;124(9):2033-41
Fetz V et al
2009/01/01
Species: Human, Applications: IHC-P, ICC/IF, WB PubMed
162 Kunze D et al. Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo. Int. J. Oncol. 2008 May;32(5):1049-56
Kunze D et al
2008/01/01
Species: Mouse, Applications: IHC-P PubMed
163 Chiappara G et al. The role of p21 Waf1/Cip1 in large airway epithelium in smokers with and without COPD. Biochim. Biophys. Acta 2013 Oct;1832(10):1473-81
Chiappara G et al
2013/01/01
Species: Human, Applications: IHC-P PubMed
164 Mellai M et al. Survivin expression in glioblastomas correlates with proliferation, but not with apoptosis. Anticancer Res. ;28(1A):109-18
Mellai M et al
Species: Human, Applications: IHC-P PubMed
165 Balkhi MY et al. AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation. Exp. Hematol. 2008 Nov;36(11):1449-60
Balkhi MY et al
2008/01/01
Species: Mouse, Applications: WB PubMed
166 Maxia C et al. Relationship between the expression of cyclooxygenase-2 and survivin in primary pterygium. Mol. Vis. 2009;15:458-63
Maxia C et al
2009/01/01
Species: Human, Applications: IHC-P PubMed
167 Qi G et al. Intracellular localization of survivin determines biological behavior in colorectal cancer. Oncol. Rep. 2009 Sep;22(3):557-62
Qi G et al
2009/01/01
Species: Human, Applications: WB PubMed
168 Wang Z et al. Targeting FoxM1 effectively retards p53-null lymphoma and sarcoma. Mol. Cancer Ther. 2013 May;12(5):759-67
Wang Z et al
2013/01/01
Species: Mouse, Applications: WB PubMed
169 Velummailum R. Involvement of NLRP5 in the maintenance of genome integrity in murine oocytes [Internet]. 2011

PubMed
170 Kunze D et al. Enhanced Inhibition of Bladder Cancer Cell Growth by Simultaneous Knockdown of Antiapoptotic Bcl-xL and Survivin in Combination with Chemotherapy. Int J Mol Sci 2013;14(6):12297-312
Kunze D et al
2013/01/01
Species: Human, Applications: WB PubMed
171 Takagi K et al. Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatment. Br. J. Cancer 2013 Jul;109(1):100-8
Takagi K et al
2013/01/01
Species: Human, Applications: IHC PubMed
172 Velmurugan B et al. Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules. Pharm. Res. 2010 Oct;27(10):2085-97
Velmurugan B et al
2010/01/01
Species: Human, Applications: IHC-P PubMed
173 Wuttig D et al. Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition? Int. J. Oncol. 2007 Jun;30(6):1317-24
Wuttig D et al
2007/01/01
Species: Human, Applications: WB, IHC-P PubMed
174 Khan S et al. Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. Br. J. Cancer 2009 Apr;100(7):1073-86
Khan S et al
2009/01/01
Species: Human, Applications: WB PubMed
175 Semrau R et al. Prognostic impact of human papillomavirus status, survivin, and epidermal growth factor receptor expression on survival in patients treated with radiochemotherapy for very advanced nonresectable oropharyngeal cancer. Head Neck 2013 Sep;35(
Semrau R et al
2013/01/01
Species: Human, Applications: IHC-P PubMed
176 Matteucci C et al. Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis. Hepatol. Res. 2013 Sep;
Matteucci C et al
2013/01/01
Species: Human, Applications: ELISA PubMed
177 Dallaglio K et al. Isolation and characterization of squamous cell carcinoma-derived stem-like cells: role in tumor formation. Int J Mol Sci 2013;14(10):19540-55
Dallaglio K et al
2013/01/01
Species: Human, Applications: IHC-P, WB PubMed
178 Knauer SK et al. Nuclear export is essential for the tumor-promoting activity of survivin. FASEB J. 2007 Jan;21(1):207-16
Knauer SK et al
2007/01/01
PubMed
179 Pannone G et al. The role of survivin in thyroid tumors: differences of expression in well-differentiated, non-well-differentiated, and anaplastic thyroid cancers. Thyroid 2014 Mar;24(3):511-9
Pannone G et al
2014/01/01
PubMed
180 Alaggio R et al. Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST). PLoS ONE 2013;8(11):e80456
Alaggio R et al
2013/01/01
PubMed
181 Taniguchi F et al. The Cellular Inhibitor of Apoptosis Protein-2 is a Possible Target of Novel Treatment for Endometriosis. Am. J. Reprod. Immunol. 2014 Mar;71(3):278-85
Taniguchi F et al
2014/01/01
PubMed
182 Zhang M et al. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients. Target Oncol 2013 Nov;
Zhang M et al
2013/01/01
PubMed
183 Yamazaki H et al. Inhibition of survivin influences the biological activities of canine histiocytic sarcoma cell lines. PLoS ONE 2013;8(11):e79810
Yamazaki H et al
2013/01/01
PubMed
184 Sayeed A et al. IGF-IR promotes prostate cancer growth by stabilizing α5β1 integrin protein levels. PLoS ONE 2013;8(10):e76513
Sayeed A et al
2013/01/01
PubMed
185 Li L et al. HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s. Clin. Cancer Res. 2013 Dec;19(24):6703-15
Li L et al
2013/01/01
PubMed
186 Cornago M et al. Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe. Cell Death Dis 2014;5:e1435
Cornago M et al
2014/01/01
Species: Human, Applications: WB, ICC/IF PubMed
187 Cao XQ et al. MEKK3 and survivin expression in cervical cancer: association with clinicopathological factors and prognosis. Asian Pac. J. Cancer Prev. 2014;15(13):5271-6
Cao XQ et al
2014/01/01
Species: Human, Applications: WB, IHC-P PubMed
188 Althoff K et al. miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin. Int. J. Cancer 2015 Mar;136(6):1308-20
Althoff K et al
2015/01/01
Species: Human, Applications: ICC/IF PubMed
189 Grazia G et al. Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma. Cell Death Dis 2014;5:e1434
Grazia G et al
2014/01/01
Species: Human, Applications: WB PubMed
190 Ram鱈rez-Labrada A et al. Two death pathways induced by sorafenib in myeloma cells: Puma-mediated apoptosis and necroptosis. Clin Transl Oncol 2014 Jul;
Ram鱈rez-Labrada A et al
2014/01/01
Species: Human, Applications: WB PubMed
191 Fu DR et al. Prognostic Utility of Apoptosis Index, Ki-67 and Survivin Expression in Dogs with Nasal Carcinoma Treated with Orthovoltage Radiation Therapy. J. Vet. Med. Sci. 2014 Aug;
Fu DR et al
2014/01/01
Species: Canine, Applications: IHC-P PubMed
192 Jin B et al. Ponatinib induces apoptosis in imatinib-resistant human mast cells by dephosphorylating mutant D816V KIT and silencing β-catenin signaling. Mol. Cancer Ther. 2014 May;13(5):1217-30
Jin B et al
2014/01/01
Species: Human, Applications: WB PubMed
193 Artesi M et al. Connexin 30 expression inhibits growth of human malignant gliomas but protects them against radiation therapy. Neuro-oncology 2014 Aug;
Artesi M et al
2014/01/01
Species: Human, Applications: WB PubMed
194 Khan S et al. Early diagnostic value of survivin and its alternative splice variants in breast cancer. BMC Cancer 2014;14:176
Khan S et al
2014/01/01
Species: Human, Applications: WB, IHC-P PubMed
195 Vogt N et al. No evidence of cell cycle dysregulation in mantle cell lymphoma in vivo. Leuk. Lymphoma 2014 Nov;:1-7
Vogt N et al
2014/01/01
Species: Human, Applications: ICC/IF PubMed
196 Lu H et al. The Expression and Role of MEKK3 in Renal Clear Cell Carcinoma. Anat Rec (Hoboken) 2014 Nov;
Lu H et al
2014/01/01
PubMed
197 Yamazaki H et al. Survivin suppressor (YM155) enhances chemotherapeutic efficacy against canine histiocytic sarcoma in murine transplantation models. Res. Vet. Sci. 2015 Apr;99:137-44
Yamazaki H et al
2015/01/01
Species: Canine, Applications: IHC-P PubMed
198 Yi XP et al. Simultaneous silencing of XIAP and survivin causes partial mesenchymal-epithelial transition of human pancreatic cancer cells via the PTEN/PI3K/Akt pathway. Mol Med Rep 2015 Jul;12(1):601-8
Yi XP et al
2015/01/01
Applications: PubMed
199 Fu DR et al. Prognostic utility of apoptosis index, Ki-67 and survivin expression in dogs with nasal carcinoma treated with orthovoltage radiation therapy. J. Vet. Med. Sci. 2014 Nov;76(11):1505-12
Fu DR et al
2014/01/01
Applications: IHC PubMed
200 Galloway NR et al. Yin Yang 1 regulates the transcriptional repression of Survivin. Biochem. Biophys. Res. Commun. 2014 Feb;445(1):208-13
Galloway NR et al
2014/01/01
Species: Human, Applications: WB PubMed
201 Kapinas K et al. microRNA-mediated survivin control of pluripotency. J. Cell. Physiol. 2015 Jan;230(1):63-70
Kapinas K et al
2015/01/01
Species: Human, PubMed
202 Bongiovanni L et al. Canine cutaneous melanocytic tumours: significance of β-catenin and survivin immunohistochemical expression. Vet. Dermatol. 2015 Aug;26(4):270-e59
Bongiovanni L et al
2015/01/01
Species: Canine, Applications: IHC-P PubMed
203 Valenzuela MM et al. Exosomes Secreted from Human Cancer Cell Lines Contain Inhibitors of Apoptosis (IAP). Cancer Microenviron 2015 Aug;8(2):65-73
Valenzuela MM et al
2015/01/01
Species: Human, Applications: WB PubMed
204 Wei W et al. Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin. Mol. Cancer 2011;10:16
Wei W et al
2011/01/01
PubMed
205 Wei W et al. Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. Mol. Cancer 2009;8:76
Wei W et al
2009/01/01
PubMed
206 Stauber RH et al. A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer. Oncotarget 2012 Jan;3(1):31-43
Stauber RH et al
2012/01/01
PubMed
207 Campisi G et al. Use of fuzzy neural networks in modeling relationships of HPV infection with apoptotic and proliferation markers in potentially malignant oral lesions. Oral Oncol. 2005 Nov;41(10):994-1004
Campisi G et al
2005/01/01
Applications: IHC PubMed
208 Bafford R et al. Angiotensin II and tumor necrosis factor-alpha upregulate survivin and Kruppel-like factor 5 in smooth muscle cells: Potential relevance to vein graft hyperplasia. Surgery 2006 Aug;140(2):289-96
Bafford R et al
2006/01/01
Applications: WB PubMed
209 Okada Y et al. A dopamine D4 receptor antagonist attenuates ischemia-induced neuronal cell damage via upregulation of neuronal apoptosis inhibitory protein. J. Cereb. Blood Flow Metab. 2005 Jul;25(7):794-806
Okada Y et al
2005/01/01
Species: Human PubMed
210 Labarrade F et al. Modulating the expression of survivin and other basal epidermal proteins protects human skin from UVB damage and oxidative stress. J Cosmet Dermatol 2015 Sep;14(3):191-203
Labarrade F et al
2015/01/01
Species: Human, Applications: IHC-P PubMed
211 Sun B et al. AAG8 promotes carcinogenesis by activating STAT3. Cell. Signal. 2014 Sep;26(9):1863-9
Sun B et al
2014/01/01
Species: Human, Applications: WB PubMed
212 Fangusaro JR et al. Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome. Br. J. Cancer 2005 Jan;92(2):359-65
Fangusaro JR et al
2005/01/01
Species: Human, Applications: WB PubMed
213 L坦pez-Royuela N et al. Bim is the key mediator of glucocorticoid-induced apoptosis and of its potentiation by rapamycin in human myeloma cells. Biochim. Biophys. Acta 2010 Feb;1803(2):311-22
L坦pez-Royuela N et al
2010/01/01
Species: Human, Applications: WB PubMed
214 Engels K et al. Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker. J. Pathol. 2007 Apr;211(5):532-40
Engels K et al
2007/01/01
Species: Human, Applications: IHC PubMed
215 Lo Muzio L et al. Expression of cell cycle markers and human papillomavirus infection in oral squamous cell carcinoma: use of fuzzy neural networks. Int. J. Cancer 2005 Jul;115(5):717-23
Lo Muzio L et al
2005/01/01
Applications: IHC PubMed
216 Yuan J et al. Upregulation of survivin during immortalization of nontransformed human fibroblasts transduced with telomerase reverse transcriptase. Oncogene 2009 Jul;28(29):2678-89
Yuan J et al
2009/01/01
Species: Human, Applications: ICC/IF PubMed
217 Weber A et al. Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice. Hepatology 2010 Apr;51(4):1226-36
Weber A et al
2010/01/01
Species: Mouse, Applications: WB PubMed
218 Emmanuel C et al. Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis. PLoS ONE 2011;6(3):e17617
Emmanuel C et al
2011/01/01
PubMed
219 Stauber RH et al. Nucleocytoplasmic shuttling and the biological activity of mouse survivin are regulated by an active nuclear export signal. Traffic 2006 Nov;7(11):1461-72
Stauber RH et al
2006/01/01
Species: Mouse, Applications: WB PubMed
220 McMurtry MS et al. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J. Clin. Invest. 2005 Jun;115(6):1479-91
McMurtry MS et al
2005/01/01
PubMed
221 Yamazaki H et al. Influence of a survivin suppressor YM155 on the chemoresistance of canine histiocytic sarcoma cells. Vet. J. 2015 Sep;205(3):375-80
Yamazaki H et al
2015/01/01
Species: Canine, Applications: WB PubMed
222 Tuncel H et al. Nuclear Aurora B and cytoplasmic Survivin expression is involved in lymph node metastasis of colorectal cancer. Oncol Lett 2012 May;3(5):1109-1114
Tuncel H et al
2012/01/01
Applications: IHC PubMed
223 Lin CY et al. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan. Oral Oncol. 2005 Jul;41(6):645-54
Lin CY et al
2005/01/01
Species: Human PubMed
224 Sulaiman MK et al. SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas. Mol. Cancer 2015;14:78
Sulaiman MK et al
2015/01/01
Species: Human, Applications: WB PubMed
225 Ng L et al. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion. Hepatology 2013 Aug;58(2):667-79
Ng L et al
2013/01/01
Species: Human, Applications: WB PubMed
226 Vischioni B et al. Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients. Mol. Cancer Ther. 2006 Nov;5(11):2905-13
Vischioni B et al
2006/01/01
Species: Human, Applications: ICC/IF PubMed
227 Kim GY et al. Expression of HuR, COX-2, and survivin in lung cancers; cytoplasmic HuR stabilizes cyclooxygenase-2 in squamous cell carcinomas. Mod. Pathol. 2011 Oct;24(10):1336-47
Kim GY et al
2011/01/01
Species: Human, Applications: IHC PubMed
228 Kunze D et al. Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, Bcl-xL, XIAP and survivin in bladder cancer cells. Int. J. Oncol. 2012 Oct;41(4):1271-7
Kunze D et al
2012/01/01
Species: Human, Applications: WB PubMed
229 El-Maarri O et al. Methylation at global LINE-1 repeats in human blood are affected by gender but not by age or natural hormone cycles. PLoS ONE 2011;6(1):e16252
El-Maarri O et al
2011/01/01
Species: Human, Applications: WB PubMed
230 Weinman EC et al. Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma. Cancer 2003 May;97(9):2203-11
Weinman EC et al
2003/01/01
Species: Human PubMed
231 Locke FL et al. Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma. J Immunother Cancer 2015;3:20
Locke FL et al
2015/01/01
Species: Human, Applications: IHC-P PubMed
232 Mehta A et al. Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid Cancer. Clin. Cancer Res. 2015 Sep;21(18):4123-32
Mehta A et al
2015/01/01
Species: Human, Applications: IHC-P PubMed
233 Zhang L et al. Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer. Oncotarget 2015 Apr;6(11):9073-85
Zhang L et al
2015/01/01
PubMed
234 Pace E et al. Carbocysteine counteracts the effects of cigarette smoke on cell growth and on the SIRT1/FoxO3 axis in bronchial epithelial cells. Exp. Gerontol. 2016 Aug;81:119-28
Pace E et al
2016/01/01
PubMed
235 Lotti R et al. Survivin Modulates Squamous Cell Carcinoma-Derived Stem-Like Cell Proliferation, Viability and Tumor Formation in Vivo. Int J Mol Sci 2016;17(1)
Lotti R et al
2016/01/01
PubMed
236 Sadowski SM et al. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis. Oncotarget 2015 Jul;6(20):18038-49
Sadowski SM et al
2015/01/01
PubMed
237 Meidhof S et al. ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat. EMBO Mol Med 2015 Jun;7(6):831-47
Meidhof S et al
2015/01/01
PubMed
238 Dumont J et al. Formin-2 is required for spindle migration and for the late steps of cytokinesis in mouse oocytes. Dev. Biol. 2007 Jan;301(1):254-65
Dumont J et al
2007/01/01
PubMed
239 Qi G et al. Nuclear Survivin expression is correlated with malignant behaviors of head and neck cancer together with Aurora-B. Oral Oncol. 2010 Apr;46(4):263-70
Qi G et al
2010/01/01
PubMed
240 Vischioni B et al. Immunohistochemical detection of nuclear survivin in NSCLC: a comparison of commercial antibodies. Histopathology 2007 Apr;50(5):671-5
Vischioni B et al
2007/01/01
PubMed
241 Iimori M et al. Phosphorylation of EB2 by Aurora B and CDK1 ensures mitotic progression and genome stability. Nat Commun 2016;7:11117
Iimori M et al
2016/01/01
PubMed
242 Allison SJ et al. Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity protein in human cervical cancer cells. Aging (Albany NY) 2009 Mar;1(3):316-27
Allison SJ et al
2009/01/01
PubMed
243 Ponnelle T et al. Cellular localisation of survivin: impact on the prognosis in colorectal cancer. J. Cancer Res. Clin. Oncol. 2005 Aug;131(8):504-10
Ponnelle T et al
2005/01/01
PubMed
244 Werner TA et al. Survivin and XIAP: two valuable biomarkers in medullary thyroid carcinoma. Br. J. Cancer 2016 Feb;114(4):427-34
Werner TA et al
2016/01/01
PubMed
245 Lan L et al. Natural product (-)-gossypol inhibits colon cancer cell growth by targeting RNA-binding protein Musashi-1. Mol Oncol 2015 Aug;9(7):1406-20
Lan L et al
2015/01/01
PubMed
246 Mahotka C et al. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas. Int. J. Cancer 2002 Jul;100(1):30-6
Mahotka C et al
2002/01/01
PubMed
247 Habtemichael N et al. Expression analysis suggests a potential cytoprotective role of Birc5 in the inner ear. Mol. Cell. Neurosci. 2010 Nov;45(3):297-305
Habtemichael N et al
2010/01/01
PubMed
248 Xie D et al. Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma. Br. J. Cancer 2006 Jan;94(1):108-14
Xie D et al
2006/01/01
PubMed
249 Wu X et al. Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling. Oncotarget 2016 Mar;7(10):11708-23
Wu X et al
2016/01/01
PubMed
250 Scase TJ et al. Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis. J. Vet. Intern. Med. ;20(1):151-8
Scase TJ et al
PubMed
251 S旦ling A et al. Autoantibodies to the inhibitor of apoptosis protein survivin in patients with brain tumors. Int. J. Oncol. 2007 Jan;30(1):123-8
S旦ling A et al
2007/01/01
PubMed
252 Hayashi N et al. Adenoviral infection of survivin antisense sensitizes prostate cancer cells to etoposide in vivo. Prostate 2005 Sep;65(1):10-9
Hayashi N et al
2005/01/01
PubMed
253 Lee S et al. Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. PLoS ONE 2010;5(6):e10995
Lee S et al
2010/01/01
PubMed
254 Pizem J et al. Survivin is a negative prognostic marker in medulloblastoma. Neuropathol. Appl. Neurobiol. 2005 Aug;31(4):422-8
Pizem J et al
2005/01/01
PubMed
255 Wang H et al. Survivin mRNA-circulating tumor cells are associated with prostate cancer metastasis. Tumour Biol. 2016 Jan;37(1):723-7
Wang H et al
2016/01/01
PubMed
256 Zhao Z et al. A role of P301L tau mutant in anti-apoptotic gene expression, cell cycle and apoptosis. Mol. Cell. Neurosci. 2003 Oct;24(2):367-79
Zhao Z et al
2003/01/01
PubMed
257 Wang B et al. Expression of NgBR is highly associated with estrogen receptor alpha and survivin in breast cancer. PLoS ONE 2013;8(11):e78083
Wang B et al
2013/01/01
PubMed
258 Habtemichael N et al. Cloning and functional characterization of the guinea pig apoptosis inhibitor protein Survivin. Gene 2010 Dec;469(1-2):9-17
Habtemichael N et al
2010/01/01
PubMed
259 Wang RH et al. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell 2008 Oct;14(4):312-23
Wang RH et al
2008/01/01
PubMed
260 Song J et al. Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion. Immunity 2005 May;22(5):621-31
Song J et al
2005/01/01
PubMed
261 Hoffarth S et al. pp32/PHAPI determines the apoptosis response of non-small-cell lung cancer. Cell Death Differ. 2008 Jan;15(1):161-70
Hoffarth S et al
2008/01/01
PubMed
262 Lo Muzio L et al. HPV DNA and survivin expression in epithelial oral carcinogenesis: a relationship? Oral Oncol. 2004 Aug;40(7):736-41
Lo Muzio L et al
2004/01/01
PubMed
263 Friedman J et al. Neoadjuvant docetaxel and capecitabine in patients with high risk prostate cancer. J. Urol. 2008 Mar;179(3):911-5; discussion 915-6
Friedman J et al
2008/01/01
PubMed
264 Jung JE et al. Survivin inhibits anti-growth effect of p53 activated by aurora B. Biochem. Biophys. Res. Commun. 2005 Nov;336(4):1164-71
Jung JE et al
2005/01/01
PubMed
265 Fukuda T et al. Putative tumor suppression function of SIRT6 in endometrial cancer. FEBS Lett. 2015 Aug;589(17):2274-81
Fukuda T et al
2015/01/01
PubMed
266 Nakata Y et al. Accumulation of α-synuclein triggered by presynaptic dysfunction. J. Neurosci. 2012 Nov;32(48):17186-96
Nakata Y et al
2012/01/01
PubMed
267 Papini D et al. TD-60 links RalA GTPase function to the CPC in mitosis. Nat Commun 2015;6:7678
Papini D et al
2015/01/01
PubMed
268 Tango Y et al. Detection of autoantibodies against survivin in sera from cancer dogs. J. Vet. Med. Sci. 2010 Jul;72(7):917-20
Tango Y et al
2010/01/01
PubMed
269 Peach G. Russia pledges $4 billion for Pharma-2020 plan. Nat. Med. 2011 May;17(5):517
Peach G
2011/01/01
PubMed
270 Taglieri L et al. Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells. Oncol Lett 2017 Sep;14(3):3832-3838
Taglieri L et al
2017/01/01
Species: Human, Applications: WB PubMed
271 Dizdar L et al. Survivin and XIAP expression in distinct tumor compartments of surgically resected gastric cancer: XIAP as a prognostic marker in diffuse and mixed type adenocarcinomas. Oncol Lett 2017 Dec;14(6):6847-6856
Dizdar L et al
2017/01/01
Species: Human, Applications: IHC PubMed
272 Nonagase Y et al. Heregulin-expressing HER2-positive breast and gastric cancer exhibited heterogeneous susceptibility to the anti-HER2 agents lapatinib, trastuzumab and T-DM1. Oncotarget 2016 Dec;7(51):84860-84871
Nonagase Y et al
2016/01/01
Species: Mouse, Applications: WB PubMed
273 Lettini G et al. TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma. Cell Death Differ. 2016 11;23(11):1792-1803
Lettini G et al
2016/01/01
Species: Human PubMed
274 Chen B et al. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling. Gastroenterology 2017 06;152(8):
Chen B et al
2017/01/01
Species: Mouse, Applications: WB PubMed
275 Margulis V et al. Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder. J. Urol. 2007 Mar;177(3):1163-8
Margulis V et al
2007/01/01
Species: Human, Applications: IHC PubMed
276 Gock M et al. Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line. World J. Gastroenterol. 2018 Sep;24(33):3749-3759
Gock M et al
2018/01/01
Species: Human, Applications: WB PubMed
277 Lee HS et al. Systematic Analysis of Compounds Specifically Targeting Telomeres and Telomerase for Clinical Implications in Cancer Therapy. Cancer Res. 2018 Nov;78(21):6282-6296
Lee HS et al
2018/01/01
Species: Human, Applications: ICC/IF PubMed
278 Novais-Cruz M et al. Mitotic progression, arrest, exit or death relies on centromere structural integrity, rather than de novo transcription. Elife 2018 08;7
Novais-Cruz M et al
2018/01/01
Species: Human, Applications: WB PubMed
279 Khan S et al. Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in extracellular vesicles (EV) from prostate cancer patients. PLoS ONE 2017;12(10):e0183122
Khan S et al
2017/01/01
Species: Human, Applications: WB PubMed
280 Alzoubi S et al. Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer. Oncotarget 2016 Jul;7(28):44505-44521
Alzoubi S et al
2016/01/01
Species: Mouse, Applications: WB PubMed
281 Taglieri L et al. The kinesin Eg5 inhibitor K858 induces apoptosis and reverses the malignant invasive phenotype in human glioblastoma cells. Invest New Drugs 2018 Feb;36(1):28-35
Taglieri L et al
2018/01/01
Species: Human, Applications: PubMed
282 Wei Q et al. Synthesis and biological evaluation of novel 2-arylvinyl-substituted naphtho[2,3-d]imidazolium halide derivatives as potent antitumor agents. Eur J Med Chem 2018 Jan;144:504-516
Wei Q et al
2018/01/01
Species: Human, Applications: PubMed
283 Troiano G et al. Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma. Int J Mol Sci 2018 Sep;19(9)
Troiano G et al
2018/01/01
Species: Human, Applications: IHC PubMed
284 Ong SM et al. Anti-tumour efficacy of etoposide alone and in combination with piroxicam against canine osteosarcoma in a xenograft model. Res. Vet. Sci. 2017 Aug;113:130-135
Ong SM et al
2017/01/01
Species: Canine, Applications: WB PubMed
285 Tung J et al. A novel 4-arm DNA/RNA Nanoconstruct triggering Rapid Apoptosis of Triple Negative Breast Cancer Cells within 24 hours. Sci Rep 2017 04;7(1):793
Tung J et al
2017/01/01
Species: Human, Applications: WB PubMed
286 Kiweler N et al. The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells. Arch. Toxicol. 2018 Jul;92(7):2227-2243
Kiweler N et al
2018/01/01
Species: Mouse, Human, Applications: PubMed
287 Makii C et al. MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53. Oncotarget 2016 Nov;7(46):75328-75338
Makii C et al
2016/01/01
Species: Human, Applications: WB PubMed
288 Liu S et al. Nuclear survivin promoted by acetylation is associated with the aggressive phenotype of oral squamous cell carcinoma. Cell Cycle 2017 May;16(9):894-902
Liu S et al
2017/01/01
Species: Human, Applications: IHC PubMed
289 Dean EJ et al. A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC. Br. J. Cancer 2010 Jan;102(1):97-103
Dean EJ et al
2010/01/01
Species: Human, Applications: WB PubMed
290 Genshaft AS et al. Multiplexed, targeted profiling of single-cell proteomes and transcriptomes in a single reaction. Genome Biol. 2016 Sep;17(1):188
Genshaft AS et al
2016/01/01
Species: Human, Applications: ICC/IF PubMed
291 Magadum A et al. Live cell screening platform identifies PPARδ as a regulator of cardiomyocyte proliferation and cardiac repair. Cell Res. 2017 Aug;27(8):1002-1019
Magadum A et al
2017/01/01
Species: Rat, Applications: ICC/IF PubMed
292 Bonora M et al. Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition. Oncogene 2015 Mar;34(12):1608
Bonora M et al
2015/01/01
PubMed
293 Kim W et al. Mitochondrial CCAR2/DBC1 is required for cell survival against rotenone-induced mitochondrial stress. Biochem. Biophys. Res. Commun. 2017 Apr;485(4):782-789
Kim W et al
2017/01/01
PubMed
294 Scuto A et al. STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphoma. Cancer Res. 2011 May;71(9):3182-8
Scuto A et al
2011/01/01
Species: Mouse, Applications: WB PubMed
295 Christenson JL et al. t-Darpp overexpression in HER2-positive breast cancer confers a survival advantage in lapatinib. Oncotarget 2015 Oct;6(32):33134-45
Christenson JL et al
2015/01/01
ICC/IF PubMed
296 Filion TM et al. Survival responses of human embryonic stem cells to DNA damage. J. Cell. Physiol. 2009 Sep;220(3):586-92
Filion TM et al
2009/01/01
Species: Human, Applications: IHC PubMed
297 Redli PM et al. The Ska complex promotes Aurora B activity to ensure chromosome biorientation. J. Cell Biol. 2016 Oct;215(1):77-93
Redli PM et al
2016/01/01
Species: Human, Applications: WB PubMed
298 Wu X et al. Innovative delivery of siRNA to solid tumors by super carbonate apatite. PLoS ONE 2015;10(3):e0116022
Wu X et al
2015/01/01
Species: Mouse, Applications: WB, ICC/IF PubMed
299 Liang C et al. A kinase-dependent role for Haspin in antagonizing Wapl and protecting mitotic centromere cohesion. EMBO Rep. 2018 01;19(1):43-56
Liang C et al
2018/01/01
ICC/IF PubMed
300 Werner TA et al. Survivin and XIAP - two potential biological targets in follicular thyroid carcinoma. Sci Rep 2017 Sep;7(1):11383
Werner TA et al
2017/01/01
Species: Human, Applications: IHC-P PubMed
301 Zhang J et al. Inhibitory effect of the anthelmintic drug pyrvinium pamoate on T315I BCR‑ABL‑positive CML cells. Mol Med Rep 2017 Dec;16(6):9217-9223
Zhang J et al
2017/01/01
Species: Human, Applications: PubMed
302 Scheer A et al. Survivin expression pattern in the intestine of normoxic and ischemic rats. BMC Gastroenterol 2017 Jun;17(1):76
Scheer A et al
2017/01/01
Species: Rat, Applications: IHC PubMed
303 Qi G et al. PARP6 acts as a tumor suppressor via downregulating Survivin expression in colorectal cancer. Oncotarget 2016 Apr;7(14):18812-24
Qi G et al
2016/01/01
WB PubMed
304 Tastekin E et al. Prognostic Value of Angiogenesis and Survivin Expression in Patients with Glioblastoma. Turk Neurosurg 2016;26(4):484-90
Tastekin E et al
2016/01/01
PubMed
305 Unruhe-Knauf B et al. Analysis of HDACi-Induced Changes in Chromosomal Passenger Complex Localization. Methods Mol. Biol. 2017;1510:47-59
Unruhe-Knauf B et al
2017/01/01
PubMed
306 Dheekollu J et al. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency. Oncotarget 2017 Jan;8(5):7248-7264
Dheekollu J et al
2017/01/01
PubMed
307 Varughese RK et al. Survivin and gliomas: A literature review. Oncol Lett 2016 Sep;12(3):1679-1686
Varughese RK et al
2016/01/01
Species: Human, Applications: IHC PubMed
308 Kreger BT et al. The Enrichment of Survivin in Exosomes from Breast Cancer Cells Treated with Paclitaxel Promotes Cell Survival and Chemoresistance. Cancers (Basel) 2016 Dec;8(12)
Kreger BT et al
2016/01/01
PubMed
309 Liu T et al. Expression of USP22 and the chromosomal passenger complex is an indicator of malignant progression in oral squamous cell carcinoma. Oncol Lett 2019 Feb;17(2):2040-2046
Liu T et al
2019/01/01
PubMed
310 Kubo T et al. Immunohistological analysis of pancreatic carcinoma after vaccination with survivin 2B peptide: Analysis of an autopsy series. Cancer Sci 2019 Aug;110(8):2386-2395
Kubo T et al
2019/01/01
PubMed
311 Brown M et al. The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC. PLoS One 2020;15(1):e0226917
Brown M et al
2020/01/01
PubMed
312 Wang H et al. Expression of survivin, MUC2 and MUC5 in colorectal cancer and their association with clinicopathological characteristics. Oncol Lett 2017 Jul;14(1):1011-1016
Wang H et al
2017/01/01
PubMed
313 Tastekin E et al. Survivin expression, HPV positivity and microvessel density in oropharyngeal carcinomas and relationship with survival time. Arch Med Sci 2017 Oct;13(6):1467-1473
Tastekin E et al
2017/01/01
PubMed
314 Erdogan S et al. Neferine inhibits proliferation and migration of human prostate cancer stem cells through p38 MAPK/JNK activation. J Food Biochem 2020 07;44(7):e13253
Erdogan S et al
2020/01/01
PubMed
315 Zhou J et al. Salinomycin effectively eliminates cancer stem-like cells and obviates hepatic metastasis in uveal melanoma. Mol Cancer 2019 11;18(1):159
Zhou J et al
2019/01/01
PubMed
316 Nourreddine S et al. NF45 and NF90 Regulate Mitotic Gene Expression by Competing with Staufen-Mediated mRNA Decay. Cell Rep 2020 05;31(7):107660
Nourreddine S et al
2020/01/01
PubMed
317 Abad MA et al. Borealin-nucleosome interaction secures chromosome association of the chromosomal passenger complex. J Cell Biol 2019 12;218(12):3912-3925
Abad MA et al
2019/01/01
PubMed
318 Thamm DH et al. Phase-I trial of survivin inhibition with EZN-3042 in dogs with spontaneous lymphoma. BMC Vet Res 2020 Mar;16(1):97
Thamm DH et al
2020/01/01
PubMed
319 Mirshahidi S et al. Inhibitory Effects of Indomethacin in Human MNNG/HOS Osteosarcoma Cell Line <i>In&#xA0;Vitro</i>. Cancer Invest 2020 Jan;38(1):23-36
Mirshahidi S et al
2020/01/01
PubMed
320 Liang C et al. Centromere-localized Aurora B kinase is required for the fidelity of chromosome segregation. J. Cell Biol. 2020 Feb;219(2)
Liang C et al
2020/01/01
PubMed
321 Rauch A et al. Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells. Oncotarget 2018 Jun;9(45):27835-27850
Rauch A et al
2018/01/01
PubMed
322 Ong SM et al. YM155 enhances the cytotoxic activity of etoposide against canine osteosarcoma cells. J Vet Med Sci 2019 Aug;81(8):1182-1190
Ong SM et al
2019/01/01
PubMed
323 Bradford EM et al. Epithelial TNF Receptor Signaling Promotes Mucosal Repair in Inflammatory Bowel Disease. J Immunol 2017 09;199(5):1886-1897
Bradford EM et al
2017/01/01
PubMed
324 Ferguson Bennit HR et al. Natural Killer Cell Phenotype and Functionality Affected by Exposure to Extracellular Survivin and Lymphoma-Derived Exosomes. Int J Mol Sci 2021 Jan;22(3)
Ferguson Bennit HR et al
2021/01/01
PubMed
325 Oliveira ALCSL et al. Maximizing the potency of oxaliplatin coated nanoparticles with folic acid for modulating tumor progression in colorectal cancer. Mater Sci Eng C Mater Biol Appl 2021 Jan;120:111678
Oliveira ALCSL et al
2021/01/01
PubMed
326 Dyshlovoy SA et al. Inspired by Sea Urchins: Warburg Effect Mediated Selectivity of Novel Synthetic Non-Glycoside 1,4-Naphthoquinone-6S-Glucose Conjugates in Prostate Cancer. Mar Drugs 2020 May;18(5)
Dyshlovoy SA et al
2020/01/01
PubMed
327 Di Vincenzo S et al. Cigarette smoke extract reduces FOXO3a promoting tumor progression and cell migration in lung cancer. Toxicology 2021 04;454:152751
Di Vincenzo S et al
2021/01/01
PubMed
328 Murillo-Pineda M et al. Induction of spontaneous human neocentromere formation and long-term maturation. J Cell Biol 2021 03;220(3)
Murillo-Pineda M et al
2021/01/01
PubMed
329 Abdo W et al. Protective effect of thymoquinone against lung intoxication induced by malathion inhalation. Sci Rep 2021 01;11(1):2498
Abdo W et al
2021/01/01
PubMed
330 Tsunematsu T et al. APC/C<sup>Cdh1</sup> is required for the termination of chromosomal passenger complex activity upon mitotic exit. J Cell Sci 2020 09;133(18)
Tsunematsu T et al
2020/01/01
PubMed
  • No.: 1
  • 文献情報:
    de Minzi MC et al. Effect of inapplicable items in the factor structure of the Spanish version of the Ways of Coping Questionnaire. Psychol Rep 2001 Feb;88(1):115-22
    de Minzi MC et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Wheatley SP et al. INCENP is required for proper targeting of Survivin to the centromeres and the anaphase spindle during mitosis. Curr. Biol. 2001 Jun;11(11):886-90
    Wheatley SP et al
    2001/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Zhu L et al. Anti-apoptotic protein survivin plays a significant role in tubular morphogenesis of human coronary arteriolar endothelial cells by hypoxic preconditioning. FEBS Lett. 2001 Nov;508(3):369-74
    Zhu L et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Chakravarti A et al. Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J. Clin. Oncol. 2002 Feb;20(4):1063-8
    Chakravarti A et al
    2002/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Fortugno P et al. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J. Cell. Sci. 2002 Feb;115(Pt 3):575-85
    Fortugno P et al
    2002/01/01
  • 備考:
    Species: Human, Applications: IP, WB, ICC/IF
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Giodini A et al. Regulation of microtubule stability and mitotic progression by survivin. Cancer Res. 2002 May;62(9):2462-7
    Giodini A et al
    2002/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Zhang C et al. Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. Clin. Cancer Res. 2002 May;8(5):1234-40
    Zhang C et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Qanungo S et al. 2-Methoxyestradiol induces mitochondria dependent apoptotic signaling in pancreatic cancer cells. Oncogene 2002 Jun;21(26):4149-57
    Qanungo S et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Yu J et al. Increased expression of survivin in gastric cancer patients and in first degree relatives. Br. J. Cancer 2002 Jul;87(1):91-7
    Yu J et al
    2002/01/01
  • 備考:
    Species: Human, Applications: WB, IHC-P
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    O&#39;Connor DS et al. A p34(cdc2) survival checkpoint in cancer. Cancer Cell 2002 Jul;2(1):43-54
    O&#39;Connor DS et al
    2002/01/01
  • 備考:
    Species: Human, Applications: WB, IP
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Blanc-Brude OP et al. Inhibitor of apoptosis protein survivin regulates vascular injury. Nat. Med. 2002 Sep;8(9):987-94
    Blanc-Brude OP et al
    2002/01/01
  • 備考:
    Species: Rat, Applications: WB, IHC-Fr, ICC/IF
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Mahotka C et al. Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ. 2002 Dec;9(12):1334-42
    Mahotka C et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Faderl S et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia. Blood 2003 Jul;102(2):630-7
    Faderl S et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Kennedy SM et al. Prognostic importance of survivin in breast cancer. Br. J. Cancer 2003 Apr;88(7):1077-83
    Kennedy SM et al
    2003/01/01
  • 備考:
    Species: Human, Applications: IHC-Fr, IHC-P
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Hauf S et al. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J. Cell Biol. 2003 Apr;161(2):281-94
    Hauf S et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Ramp U et al. Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage. Br. J. Cancer 2003 Jun;88(11):1800-7
    Ramp U et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Carvalho A et al. Survivin is required for stable checkpoint activation in taxol-treated HeLa cells. J. Cell. Sci. 2003 Jul;116(Pt 14):2987-98
    Carvalho A et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Blanc-Brude OP et al. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin. Cancer Res. 2003 Jul;9(7):2683-92
    Blanc-Brude OP et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Chen Y et al. Loss of inhibitor of apoptosis proteins as a determinant of polyamine analog-induced apoptosis in human melanoma cells. Oncogene 2003 Aug;22(32):4964-72
    Chen Y et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Honda R et al. Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis. Mol. Biol. Cell 2003 Aug;14(8):3325-41
    Honda R et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Neef R et al. Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis. J. Cell Biol. 2003 Sep;162(5):863-75
    Neef R et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Fornaro M et al. Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway. J. Biol. Chem. 2003 Dec;278(50):50402-11
    Fornaro M et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Beltrami E et al. Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis. J. Biol. Chem. 2004 Jan;279(3):2077-84
    Beltrami E et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Altura RA et al. Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade. Br. J. Cancer 2003 Nov;89(9):1743-9
    Altura RA et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Krysan K et al. COX-2-dependent stabilization of survivin in non-small cell lung cancer. FASEB J. 2004 Jan;18(1):206-8
    Krysan K et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Fortugno P et al. Regulation of survivin function by Hsp90. Proc. Natl. Acad. Sci. U.S.A. 2003 Nov;100(24):13791-6
    Fortugno P et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Chen JG et al. Gene expression and mitotic exit induced by microtubule-stabilizing drugs. Cancer Res. 2003 Nov;63(22):7891-9
    Chen JG et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Lo Muzio L et al. Survivin expression in oral squamous cell carcinoma. Br. J. Cancer 2003 Dec;89(12):2244-8
    Lo Muzio L et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Liu T et al. Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells. Oncogene 2004 Jan;23(1):39-48
    Liu T et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Kirkiles-Smith NC et al. IL-11 protects human microvascular endothelium from alloinjury in vivo by induction of survivin expression. J. Immunol. 2004 Feb;172(3):1391-6
    Kirkiles-Smith NC et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Martinez A et al. Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival. Am. J. Pathol. 2004 Feb;164(2):501-10
    Martinez A et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Zha H et al. Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray. Lab. Invest. 2004 Feb;84(2):235-44
    Zha H et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Asanuma K et al. Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells. J. Immunol. 2004 Mar;172(6):3922-9
    Asanuma K et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Johnson VL et al. Bub1 is required for kinetochore localization of BubR1, Cenp-E, Cenp-F and Mad2, and chromosome congression. J. Cell. Sci. 2004 Mar;117(Pt 8):1577-89
    Johnson VL et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Schlette EJ et al. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. J. Clin. Oncol. 2004 May;22(9):1682-8
    Schlette EJ et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Geddis AE et al. Megakaryocytes express functional Aurora-B kinase in endomitosis. Blood 2004 Aug;104(4):1017-24
    Geddis AE et al
    2004/01/01
  • 備考:
    Species: Mouse, Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Gassmann R et al. Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle. J. Cell Biol. 2004 Jul;166(2):179-91
    Gassmann R et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Chakravarti A et al. Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. Oncogene 2004 Sep;23(45):7494-506
    Chakravarti A et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Mallikarjuna G et al. Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling. Cancer Res. 2004 Sep;64(17):6349-56
    Mallikarjuna G et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Chen JS et al. Cancer-specific activation of the survivin promoter and its potential use in gene therapy. Cancer Gene Ther. 2004 Nov;11(11):740-7
    Chen JS et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Krysan K et al. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer. Cancer Res. 2004 Sep;64(18):6359-62
    Krysan K et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Ferrer A et al. Activation of mitochondrial apoptotic pathway in mantle cell lymphoma: high sensitivity to mitoxantrone in cases with functional DNA-damage response genes. Oncogene 2004 Nov;23(55):8941-9
    Ferrer A et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Scrittori L et al. A small C-terminal sequence of Aurora B is responsible for localization and function. Mol. Biol. Cell 2005 Jan;16(1):292-305
    Scrittori L et al
    2005/01/01
  • 備考:
    Species: Human, Applications: ICC/IF, WB
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Vischioni B et al. Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer. Ann. Oncol. 2004 Nov;15(11):1654-60
    Vischioni B et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    MacCallum DE et al. Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1. Cancer Res. 2005 Jun;65(12):5399-407
    MacCallum DE et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Pennati M et al. Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation. Mol. Cancer Ther. 2005 Sep;4(9):1328-37
    Pennati M et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Hata T et al. Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells. Mol. Cancer Ther. 2005 Oct;4(10):1585-94
    Hata T et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Kim EY et al. TNF receptor type 2 (p75) functions as a costimulator for antigen-driven T cell responses in vivo. J. Immunol. 2006 Jan;176(2):1026-35
    Kim EY et al
    2006/01/01
  • 備考:
    Species: Mouse, Applications: FLOW, ICC/IF
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Mao JT et al. Celecoxib decreases Ki-67 proliferative index in active smokers. Clin. Cancer Res. 2006 Jan;12(1):314-20
    Mao JT et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Farheen S et al. Gilbert&#39;s syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene. World J. Gastroenterol. 2006 Apr;12(14):2269-75
    Farheen S et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Fukuda S et al. Survivin, a cancer target with an emerging role in normal adult tissues. Mol. Cancer Ther. 2006 May;5(5):1087-98
    Fukuda S et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Kang BH et al. Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein. J. Biol. Chem. 2006 Aug;281(34):24721-7
    Kang BH et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Hahn JY et al. Beta-catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts. J. Biol. Chem. 2006 Oct;281(41):30979-89
    Hahn JY et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Yip KW et al. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Clin. Cancer Res. 2006 Oct;12(19):5726-32
    Yip KW et al
    2006/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Caldas H et al. Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis. Blood 2007 Feb;109(4):1479-89
    Caldas H et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Deep G et al. Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells. Carcinogenesis 2007 Jul;28(7):1533-42
    Deep G et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Huang H et al. Tripin/hSgo2 recruits MCAK to the inner centromere to correct defective kinetochore attachments. J. Cell Biol. 2007 May;177(3):413-24
    Huang H et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Gong J et al. Attenuation of apoptosis by chromogranin A-induced Akt and survivin pathways in prostate cancer cells. Endocrinology 2007 Sep;148(9):4489-99
    Gong J et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Kindt N et al. Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced acute renal failure. FASEB J. 2008 Feb;22(2):510-21
    Kindt N et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Niedbala W et al. Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25 T cells via p53, IL-2, and OX40. Proc. Natl. Acad. Sci. U.S.A. 2007 Sep;104(39):15478-83
    Niedbala W et al
    2007/01/01
  • 備考:
    Species: Mouse, Applications: FLOW
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Lechler P et al. The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney. Am. J. Pathol. 2007 Nov;171(5):1483-98
    Lechler P et al
    2007/01/01
  • 備考:
    Species: Human, Rat, Mouse, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Moiseeva EP et al. Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells. Mol. Cancer Ther. 2007 Nov;6(11):3071-9
    Moiseeva EP et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Skoufias DA et al. Mitosis persists in the absence of Cdk1 activity when proteolysis or protein phosphatase activity is suppressed. J. Cell Biol. 2007 Nov;179(4):671-85
    Skoufias DA et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Connell CM et al. Nuclear survivin has reduced stability and is not cytoprotective. J. Biol. Chem. 2008 Feb;283(6):3289-96
    Connell CM et al
    2008/01/01
  • 備考:
    ImmunoPrecipitation
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Ghosh JC et al. Hsp60 regulation of tumor cell apoptosis. J. Biol. Chem. 2008 Feb;283(8):5188-94
    Ghosh JC et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Tyagi A et al. Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice. Mol. Cancer Ther. 2007 Dec;6(12 Pt 1):3248-55
    Tyagi A et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Singh RP et al. Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin. Clin. Cancer Res. 2008 Jan;14(1):300-8
    Singh RP et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Niibe Y et al. Concomitant expression of HER2 and HIF-1alpha is a predictor of poor prognosis in uterine cervical carcinoma treated with concurrent chemoradiotherapy: prospective analysis (KGROG0501). Eur. J. Gynaecol. Oncol. 2010;31(5):491-6
    Niibe Y et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    AbouAlaiwi WA et al. Endothelial cells from humans and mice with polycystic kidney disease are characterized by polyploidy and chromosome segregation defects through survivin down-regulation. Hum. Mol. Genet. 2011 Jan;20(2):354-67
    AbouAlaiwi WA et al
    2011/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Asanuma H et al. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Res. 2005 Dec;65(23):
    Asanuma H et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Thirunavukkarasu M et al. Adeno-sh-beta-catenin abolishes ischemic preconditioning-mediated cardioprotection by downregulation of its target genes VEGF, Bcl-2, and survivin in ischemic rat myocardium. Antioxid. Redox Signal. 2008 Aug;10(8):1475-84
    Thirunavukkarasu M et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Fossey SL et al. The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines. BMC Cancer 2011;11:112
    Fossey SL et al
    2011/01/01
  • 備考:
    Species: Human, Canine, Applications: WB
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Lou Y et al. Oral administration of caffeine during voluntary exercise markedly decreases tissue fat and stimulates apoptosis and cyclin B1 in UVB-treated skin of hairless p53-knockout mice. Carcinogenesis 2010 Apr;31(4):671-8
    Lou Y et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    Miranda MB et al. Differential activation of apoptosis regulatory pathways during monocytic vs granulocytic differentiation: a requirement for Bcl-X(L)and XIAP in the prolonged survival of monocytic cells. Leukemia 2003 Feb;17(2):390-400
    Miranda MB et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    Finkelstein SE et al. Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients. Int. J. Radiat. Oncol. Biol. Phys. 2012 Feb;82(2):924-32
    Finkelstein SE et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 76
  • 文献情報:
    Chiou SK et al. Sulindac sulfide induces autophagic death in gastric epithelial cells via survivin down-regulation: a mechanism of NSAIDs-induced gastric injury. Biochem. Pharmacol. 2011 Jun;81(11):1317-23
    Chiou SK et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 77
  • 文献情報:
    Robles AI et al. Schedule-dependent synergy between the heat shock protein 90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin and doxorubicin restores apoptosis to p53-mutant lymphoma cell lines. Clin. Cancer Res. 2006 Nov;12(21):6547-56
    Robles AI et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 78
  • 文献情報:
    Lubet RA et al. 4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin. Carcinogenesis 2005 Mar;26(3):571-8
    Lubet RA et al
    2005/01/01
  • 備考:
    Species: Mouse, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 79
  • 文献情報:
    El Ghamrasni S et al. Inactivation of chk2 and mus81 leads to impaired lymphocytes development, reduced genomic instability, and suppression of cancer. PLoS Genet. 2011 May;7(5):e1001385
    El Ghamrasni S et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 80
  • 文献情報:
    Zhang L et al. Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 2008 Dec;105(49):19532-7
    Zhang L et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 81
  • 文献情報:
    Felisiak-Golabek A et al. Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients. J Ovarian Res 2011;4(1):20
    Felisiak-Golabek A et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 82
  • 文献情報:
    Hebb AL et al. Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination. Mult. Scler. 2008 Jun;14(5):577-94
    Hebb AL et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 83
  • 文献情報:
    Lechler P et al. The antiapoptotic gene survivin is highly expressed in human chondrosarcoma and promotes drug resistance in chondrosarcoma cells in vitro. BMC Cancer 2011;11:120
    Lechler P et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 84
  • 文献情報:
    Jacob NK et al. Survivin splice variants are not essential for mitotic progression or inhibition of apoptosis induced by doxorubicin and radiation. Onco Targets Ther 2012;5:7-20
    Jacob NK et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 85
  • 文献情報:
    Seo SI et al. BKM1740, an acyl-tyrosine bisphosphonate amide derivative, inhibits the bone metastatic growth of human prostate cancer cells by inducing apoptosis. Clin. Cancer Res. 2008 Oct;14(19):6198-206
    Seo SI et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 86
  • 文献情報:
    Kim SH et al. Garlic constituent diallyl trisulfide suppresses x-linked inhibitor of apoptosis protein in prostate cancer cells in culture and in vivo. Cancer Prev Res (Phila) 2011 Jun;4(6):897-906
    Kim SH et al
    2011/01/01
  • 備考:
    Species: Human, Mouse, Applications: WB, IHC
  • 参照:
    PubMed
  • No.: 87
  • 文献情報:
    Francisco R et al. Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells. Cancer Lett. 2012 May;318(1):42-52
    Francisco R et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 88
  • 文献情報:
    Lechler P et al. The oncofetal gene survivin is re-expressed in osteoarthritis and is required for chondrocyte proliferation in vitro. BMC Musculoskelet Disord 2011;12:150
    Lechler P et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 89
  • 文献情報:
    Shariat SF et al. Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study. Clin. Cancer Res. 2009 Nov;15(22):7012-9
    Shariat SF et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 90
  • 文献情報:
    Eberhard Y et al. Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells. Blood 2009 Oct;114(14):3064-73
    Eberhard Y et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 91
  • 文献情報:
    Lee JH et al. Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation. Am. J. Physiol., Cell Physiol. 2009 Feb;296(2):C327-38
    Lee JH et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 92
  • 文献情報:
    Adler M et al. Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity. Carcinogenesis 2009 Apr;30(4):711-9
    Adler M et al
    2009/01/01
  • 備考:
    Species: Rat, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 93
  • 文献情報:
    Talbot DC et al. Tumor survivin is downregulated by the antisense oligonucleotide LY2181308: a proof-of-concept, first-in-human dose study. Clin. Cancer Res. 2010 Dec;16(24):6150-8
    Talbot DC et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 94
  • 文献情報:
    Lu J et al. Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistance. Clin. Cancer Res. 2009 Feb;15(4):1326-34
    Lu J et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 95
  • 文献情報:
    Xu Y et al. A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol. 2004 Sep;23(9):527-37
    Xu Y et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 96
  • 文献情報:
    Song KY et al. Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma. Jpn. J. Clin. Oncol. 2009 May;39(5):290-6
    Song KY et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 97
  • 文献情報:
    Kavitha CV et al. Asiatic acid inhibits pro-angiogenic effects of VEGF and human gliomas in endothelial cell culture models. PLoS ONE 2011;6(8):e22745
    Kavitha CV et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 98
  • 文献情報:
    Zeitlin SG et al. CENP-A is phosphorylated by Aurora B kinase and plays an unexpected role in completion of cytokinesis. J. Cell Biol. 2001 Dec;155(7):1147-57
    Zeitlin SG et al
    2001/01/01
  • 備考:
    Species: Human, Applications: WB, ICC/IF
  • 参照:
    PubMed
  • No.: 99
  • 文献情報:
    Lee CW et al. Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. Cancer Res. 2008 Jul;68(13):5273-81
    Lee CW et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 100
  • 文献情報:
    Borghouts C et al. Monomeric recombinant peptide aptamers are required for efficient intracellular uptake and target inhibition. Mol. Cancer Res. 2008 Feb;6(2):267-81
    Borghouts C et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 101
  • 文献情報:
    Kim EY et al. TNFR2-deficient memory CD8 T cells provide superior protection against tumor cell growth. J. Immunol. 2009 Nov;183(10):6051-7
    Kim EY et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 102
  • 文献情報:
    Amin HM et al. Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma. Oncogene 2004 Jul;23(32):5426-34
    Amin HM et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 103
  • 文献情報:
    Symes JC et al. Fas-mediated killing of primary prostate cancer cells is increased by mitoxantrone and docetaxel. Mol. Cancer Ther. 2008 Sep;7(9):3018-28
    Symes JC et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 104
  • 文献情報:
    Dai Y et al. Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis. Clin. Cancer Res. 2008 Dec;14(23):7701-10
    Dai Y et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 105
  • 文献情報:
    Komuro Y et al. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis. Mod. Pathol. 2004 Feb;17(2):264
    Komuro Y et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 106
  • 文献情報:
    Guha M et al. Endogenous tumor suppression mediated by PTEN involves survivin gene silencing. Cancer Res. 2009 Jun;69(12):4954-8
    Guha M et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 107
  • 文献情報:
    Engels K et al. NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas. Cancer Res. 2008 Jul;68(13):5159-66
    Engels K et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 108
  • 文献情報:
    Xia F et al. A survivin-ran complex regulates spindle formation in tumor cells. Mol. Cell. Biol. 2008 Sep;28(17):5299-311
    Xia F et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 109
  • 文献情報:
    Rudkowski JC et al. Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis. Am. J. Physiol. Lung Cell Mol. Physiol. 2004 Apr;286(4):L793-800
    Rudkowski JC et al
    2004/01/01
  • 備考:
    Species: Rat, Applications: WB
  • 参照:
    PubMed
  • No.: 110
  • 文献情報:
    Xia M et al. p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation. Oncogene 2011 Jan;30(3):346-55
    Xia M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 111
  • 文献情報:
    Schaue D et al. T-cell responses to survivin in cancer patients undergoing radiation therapy. Clin. Cancer Res. 2008 Aug;14(15):4883-90
    Schaue D et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 112
  • 文献情報:
    Gould Rothberg BE et al. Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis. J. Natl. Cancer Inst. 2009 Apr;101(7):452-74
    Gould Rothberg BE et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 113
  • 文献情報:
    Grabowski P et al. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br. J. Cancer 2003 Jan;88(1):115-9
    Grabowski P et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 114
  • 文献情報:
    Khan S et al. Survivin is released from cancer cells via exosomes. Apoptosis 2011 Jan;16(1):1-12
    Khan S et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 115
  • 文献情報:
    Jiang X et al. Imatinib targeting of KIT-mutant oncoprotein in melanoma. Clin. Cancer Res. 2008 Dec;14(23):7726-32
    Jiang X et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 116
  • 文献情報:
    Xia F et al. Tumor cell dependence on Ran-GTP-directed mitosis. Cancer Res. 2008 Mar;68(6):1826-33
    Xia F et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 117
  • 文献情報:
    Chun KS et al. The prostaglandin E2 receptor, EP2, regulates survivin expression via an EGFR/STAT3 pathway in UVB-exposed mouse skin. Mol. Carcinog. 2011 Jun;50(6):439-48
    Chun KS et al
    2011/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 118
  • 文献情報:
    Chen B et al. Rapamycin decreases survivin expression to induce NSCLC cell apoptosis under hypoxia through inhibiting HIF-1&#x3B1; induction. Mol. Biol. Rep. 2012 Jan;39(1):185-91
    Chen B et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 119
  • 文献情報:
    Lechler P et al. The oncofetal gene survivin promotes cell proliferation and survival in primary human osteoblastic cells. Calcif. Tissue Int. 2011 Sep;89(3):211-20
    Lechler P et al
    2011/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 120
  • 文献情報:
    Page BD et al. Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain. Bioorg. Med. Chem. Lett. 2011 Sep;21(18):5605-9
    Page BD et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 121
  • 文献情報:
    Saxena P et al. PSA regulates androgen receptor expression in prostate cancer cells. Prostate 2012 May;72(7):769-76
    Saxena P et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 122
  • 文献情報:
    D鱈az A et al. Pigmented spindle cell nevus: clues for differentiating it from spindle cell malignant melanoma. A comprehensive survey including clinicopathologic, immunohistochemical, and FISH studies. Am. J. Surg. Pathol. 2011 Nov;35(11):1733-42
    D鱈az A et al
    2011/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 123
  • 文献情報:
    Yakirevich E et al. Total Survivin and acetylated Survivin correlate with distinct molecular subtypes of breast cancer. Hum. Pathol. 2012 Jun;43(6):865-73
    Yakirevich E et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 124
  • 文献情報:
    Dhawan D et al. DNMT1: An emerging target in the treatment of invasive urinary bladder cancer. Urol Oncol 2012 May;
    Dhawan D et al
    2012/01/01
  • 備考:
    Species: canine, Applications: WB
  • 参照:
    PubMed
  • No.: 125
  • 文献情報:
    de Souza HS et al. Increased Levels of Survivin, via Association With Heat Shock Protein 90, in Mucosal T Cells From Patients With Crohn&#39;s Disease. Gastroenterology 2012 Oct;143(4):1017-1026.e9
    de Souza HS et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC, ICC/IF, IP
  • 参照:
    PubMed
  • No.: 126
  • 文献情報:
    . ;

  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 127
  • 文献情報:
    Chao C et al. Epstein-Barr Virus Infection and Expression of B-cell Oncogenic Markers in HIV-Related Diffuse Large B-cell Lymphoma. Clin. Cancer Res. 2012 Sep;18(17):4702-4712
    Chao C et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 128
  • 文献情報:
    Bongiovanni L et al. Nuclear survivin expression as a potentially useful tool for the diagnosis of canine cutaneous sebaceous lesions. Vet. Dermatol. 2012 Oct;23(5):394-e73
    Bongiovanni L et al
    2012/01/01
  • 備考:
    Species: Canine, Applications: IHC
  • 参照:
    PubMed
  • No.: 129
  • 文献情報:
    Jiang C et al. Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion. World J. Gastroenterol. 2012 Jun;18(23):2956-65
    Jiang C et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 130
  • 文献情報:
    Ebata A et al. Oestrogen-induced genes in ductal carcinoma in situ: their comparison with invasive ductal carcinoma. Endocr. Relat. Cancer 2012 Aug;19(4):485-96
    Ebata A et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 131
  • 文献情報:
    Velummailum R. Involvement of NLRP5 in the maintenance of genome integrity in murine oocytes [Internet]. 2011.

  • 備考:
  • 参照:
    PubMed
  • No.: 132
  • 文献情報:
    Bongiovanni L et al. Immunohistochemical investigation of cell cycle and apoptosis regulators (Survivin, &#x3B2;-Catenin, P53, Caspase 3) in canine appendicular osteosarcoma. BMC Vet. Res. 2012;8:78
    Bongiovanni L et al
    2012/01/01
  • 備考:
    Species: Canine, Applications: IHC
  • 参照:
    PubMed
  • No.: 133
  • 文献情報:
    Jia L et al. ROC1/RBX1 E3 ubiquitin ligase silencing suppresses tumor cell growth via sequential induction of G2-M arrest, apoptosis, and senescence. Cancer Res. 2009 Jun;69(12):4974-82
    Jia L et al
    2009/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 134
  • 文献情報:
    Min L et al. Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat. Cell Biol. 2012 Nov;14(11):1203-11
    Min L et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 135
  • 文献情報:
    Wang F et al. Haspin inhibitors reveal centromeric functions of Aurora B in chromosome segregation. J. Cell Biol. 2012 Oct;199(2):251-68
    Wang F et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 136
  • 文献情報:
    Erba HP et al. Safety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia (AML). Invest New Drugs 2013 Feb;
    Erba HP et al
    2013/01/01
  • 備考:
    Species: Human, Applications: ELISA
  • 参照:
    PubMed
  • No.: 137
  • 文献情報:
    Kan CY et al. Upregulation of survivin during immortalization of human myofibroblasts is linked to repression of tumor suppressor p16INK4a and confers resistance to oxidative stress. J. Biol. Chem. 2013 Feb;
    Kan CY et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 138
  • 文献情報:
    D鱈az R et al. Differential regulation of TP73 isoforms by 1&#x3B1;,25-dihydroxyvitamin D3 and survivin in human colon and breast carcinomas. Genes Chromosomes Cancer 2010 Dec;49(12):1135-42
    D鱈az R et al
    2010/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 139
  • 文献情報:
    Hori M et al. The detergent-soluble cytoplasmic pool of survivin suppresses anoikis and its expression is associated with metastatic disease of human colon cancer. PLoS ONE 2013;8(2):e55710
    Hori M et al
    2013/01/01
  • 備考:
    Species: Human, Hamster, Applications: WB
  • 参照:
    PubMed
  • No.: 140
  • 文献情報:
    Bongiovanni L et al. Epithelial-to-mesenchymal transition: immunohistochemical investigation of related molecules in canine cutaneous epithelial tumours. Vet. Dermatol. 2013 Feb;24(1):195-203.e42-3
    Bongiovanni L et al
    2013/01/01
  • 備考:
    Species: Canine, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 141
  • 文献情報:
    Knauer SK et al. Functional characterization of novel mutations affecting survivin (BIRC5)-mediated therapy resistance in head and neck cancer patients. Hum. Mutat. 2013 Feb;34(2):395-404
    Knauer SK et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 142
  • 文献情報:
    Sun Y et al. Inhibition of STAT signalling in bladder cancer by diindolylmethane: relevance to cell adhesion, migration and proliferation. Curr Cancer Drug Targets 2013 Jan;13(1):57-68
    Sun Y et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 143
  • 文献情報:
    Dallaglio K et al. E-FABP induces differentiation in normal human keratinocytes and modulates the differentiation process in psoriatic keratinocytes in vitro. Exp. Dermatol. 2013 Apr;22(4):255-61
    Dallaglio K et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 144
  • 文献情報:
    Gnana-Prakasam JP et al. Loss of Hfe leads to progression of tumor phenotype in primary retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 2013 Jan;54(1):63-71
    Gnana-Prakasam JP et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 145
  • 文献情報:
    Chiou SK et al. Nutrient availability alters the effect of autophagy on sulindac sulfide-induced colon cancer cell apoptosis. Gastroenterol Res Pract 2012;2012:897678
    Chiou SK et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 146
  • 文献情報:
    R端ckert F et al. Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis. BMC Cancer 2010;10:379
    R端ckert F et al
    2010/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 147
  • 文献情報:
    Goel HL et al. &#x3B2;1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase1. J. Cell. Physiol. 2013 Jan;
    Goel HL et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 148
  • 文献情報:
    Cheng CW et al. PIN1 inhibits apoptosis in hepatocellular carcinoma through modulation of the antiapoptotic function of survivin. Am. J. Pathol. 2013 Mar;182(3):765-75
    Cheng CW et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 149
  • 文献情報:
    Chock KL et al. BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells. Cancer Res. 2010 Nov;70(21):8782-91
    Chock KL et al
    2010/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 150
  • 文献情報:
    Knauer SK et al. An otoprotective role for the apoptosis inhibitor protein survivin. Cell Death Dis 2010;1:e51
    Knauer SK et al
    2010/01/01
  • 備考:
    Species: Guinea Pig, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 151
  • 文献情報:
    Wimmershoff J et al. Immunohistochemical detection of survivin in canine lymphoma. J. Comp. Pathol. 2010 May;142(4):311-22
    Wimmershoff J et al
    2010/01/01
  • 備考:
    Species: Canine, Applications: IHC
  • 参照:
    PubMed
  • No.: 152
  • 文献情報:
    Tecleab A et al. Depletion of K-Ras promotes proteasome degradation of survivin. Cell Cycle 2013 Feb;12(3):522-32
    Tecleab A et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IP
  • 参照:
    PubMed
  • No.: 153
  • 文献情報:
    Baba HA et al. Survivin is upregulated during liver regeneration in rats and humans and is associated with hepatocyte proliferation. Liver Int. 2009 Apr;29(4):585-92
    Baba HA et al
    2009/01/01
  • 備考:
    Species: Rat, Applications: IHC-P, WB
  • 参照:
    PubMed
  • No.: 154
  • 文献情報:
    Svec J et al. Enhanced expression of proproliferative and antiapoptotic genes in ulcerative colitis-associated neoplasia. Inflamm. Bowel Dis. 2010 Jul;16(7):1127-37
    Svec J et al
    2010/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 155
  • 文献情報:
    Kabbarah O et al. Integrative genome comparison of primary and metastatic melanomas. PLoS ONE 2010;5(5):e10770
    Kabbarah O et al
    2010/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 156
  • 文献情報:
    Honegger A et al. Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells. Int. J. Cancer 2013 Oct;133(7):1631-42
    Honegger A et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 157
  • 文献情報:
    Tyagi A et al. Differential effect of grape seed extract against human non-small-cell lung cancer cells: the role of reactive oxygen species and apoptosis induction. Nutr Cancer 2013;65 Suppl 1:44-53
    Tyagi A et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 158
  • 文献情報:
    Appleyard MV et al. Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model. Int. J. Cancer 2009 Jan;124(2):465-72
    Appleyard MV et al
    2009/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 159
  • 文献情報:
    Slagter-J辰ger JG et al. Evaluation of RNA Amplification Methods to Improve DC Immunotherapy Antigen Presentation and Immune Response. Mol Ther Nucleic Acids 2013;2:e91
    Slagter-J辰ger JG et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 160
  • 文献情報:
    Augello C et al. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma. BMC Cancer 2009;9:125
    Augello C et al
    2009/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 161
  • 文献情報:
    Fetz V et al. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin. Int. J. Cancer 2009 May;124(9):2033-41
    Fetz V et al
    2009/01/01
  • 備考:
    Species: Human, Applications: IHC-P, ICC/IF, WB
  • 参照:
    PubMed
  • No.: 162
  • 文献情報:
    Kunze D et al. Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo. Int. J. Oncol. 2008 May;32(5):1049-56
    Kunze D et al
    2008/01/01
  • 備考:
    Species: Mouse, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 163
  • 文献情報:
    Chiappara G et al. The role of p21 Waf1/Cip1 in large airway epithelium in smokers with and without COPD. Biochim. Biophys. Acta 2013 Oct;1832(10):1473-81
    Chiappara G et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 164
  • 文献情報:
    Mellai M et al. Survivin expression in glioblastomas correlates with proliferation, but not with apoptosis. Anticancer Res. ;28(1A):109-18
    Mellai M et al
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 165
  • 文献情報:
    Balkhi MY et al. AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation. Exp. Hematol. 2008 Nov;36(11):1449-60
    Balkhi MY et al
    2008/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 166
  • 文献情報:
    Maxia C et al. Relationship between the expression of cyclooxygenase-2 and survivin in primary pterygium. Mol. Vis. 2009;15:458-63
    Maxia C et al
    2009/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 167
  • 文献情報:
    Qi G et al. Intracellular localization of survivin determines biological behavior in colorectal cancer. Oncol. Rep. 2009 Sep;22(3):557-62
    Qi G et al
    2009/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 168
  • 文献情報:
    Wang Z et al. Targeting FoxM1 effectively retards p53-null lymphoma and sarcoma. Mol. Cancer Ther. 2013 May;12(5):759-67
    Wang Z et al
    2013/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 169
  • 文献情報:
    Velummailum R. Involvement of NLRP5 in the maintenance of genome integrity in murine oocytes [Internet]. 2011

  • 備考:
  • 参照:
    PubMed
  • No.: 170
  • 文献情報:
    Kunze D et al. Enhanced Inhibition of Bladder Cancer Cell Growth by Simultaneous Knockdown of Antiapoptotic Bcl-xL and Survivin in Combination with Chemotherapy. Int J Mol Sci 2013;14(6):12297-312
    Kunze D et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 171
  • 文献情報:
    Takagi K et al. Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatment. Br. J. Cancer 2013 Jul;109(1):100-8
    Takagi K et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 172
  • 文献情報:
    Velmurugan B et al. Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules. Pharm. Res. 2010 Oct;27(10):2085-97
    Velmurugan B et al
    2010/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 173
  • 文献情報:
    Wuttig D et al. Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition? Int. J. Oncol. 2007 Jun;30(6):1317-24
    Wuttig D et al
    2007/01/01
  • 備考:
    Species: Human, Applications: WB, IHC-P
  • 参照:
    PubMed
  • No.: 174
  • 文献情報:
    Khan S et al. Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. Br. J. Cancer 2009 Apr;100(7):1073-86
    Khan S et al
    2009/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 175
  • 文献情報:
    Semrau R et al. Prognostic impact of human papillomavirus status, survivin, and epidermal growth factor receptor expression on survival in patients treated with radiochemotherapy for very advanced nonresectable oropharyngeal cancer. Head Neck 2013 Sep;35(
    Semrau R et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 176
  • 文献情報:
    Matteucci C et al. Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis. Hepatol. Res. 2013 Sep;
    Matteucci C et al
    2013/01/01
  • 備考:
    Species: Human, Applications: ELISA
  • 参照:
    PubMed
  • No.: 177
  • 文献情報:
    Dallaglio K et al. Isolation and characterization of squamous cell carcinoma-derived stem-like cells: role in tumor formation. Int J Mol Sci 2013;14(10):19540-55
    Dallaglio K et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC-P, WB
  • 参照:
    PubMed
  • No.: 178
  • 文献情報:
    Knauer SK et al. Nuclear export is essential for the tumor-promoting activity of survivin. FASEB J. 2007 Jan;21(1):207-16
    Knauer SK et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 179
  • 文献情報:
    Pannone G et al. The role of survivin in thyroid tumors: differences of expression in well-differentiated, non-well-differentiated, and anaplastic thyroid cancers. Thyroid 2014 Mar;24(3):511-9
    Pannone G et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 180
  • 文献情報:
    Alaggio R et al. Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST). PLoS ONE 2013;8(11):e80456
    Alaggio R et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 181
  • 文献情報:
    Taniguchi F et al. The Cellular Inhibitor of Apoptosis Protein-2 is a Possible Target of Novel Treatment for Endometriosis. Am. J. Reprod. Immunol. 2014 Mar;71(3):278-85
    Taniguchi F et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 182
  • 文献情報:
    Zhang M et al. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients. Target Oncol 2013 Nov;
    Zhang M et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 183
  • 文献情報:
    Yamazaki H et al. Inhibition of survivin influences the biological activities of canine histiocytic sarcoma cell lines. PLoS ONE 2013;8(11):e79810
    Yamazaki H et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 184
  • 文献情報:
    Sayeed A et al. IGF-IR promotes prostate cancer growth by stabilizing &#x3B1;5&#x3B2;1 integrin protein levels. PLoS ONE 2013;8(10):e76513
    Sayeed A et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 185
  • 文献情報:
    Li L et al. HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s. Clin. Cancer Res. 2013 Dec;19(24):6703-15
    Li L et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 186
  • 文献情報:
    Cornago M et al. Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe. Cell Death Dis 2014;5:e1435
    Cornago M et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB, ICC/IF
  • 参照:
    PubMed
  • No.: 187
  • 文献情報:
    Cao XQ et al. MEKK3 and survivin expression in cervical cancer: association with clinicopathological factors and prognosis. Asian Pac. J. Cancer Prev. 2014;15(13):5271-6
    Cao XQ et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB, IHC-P
  • 参照:
    PubMed
  • No.: 188
  • 文献情報:
    Althoff K et al. miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin. Int. J. Cancer 2015 Mar;136(6):1308-20
    Althoff K et al
    2015/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 189
  • 文献情報:
    Grazia G et al. Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma. Cell Death Dis 2014;5:e1434
    Grazia G et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 190
  • 文献情報:
    Ram鱈rez-Labrada A et al. Two death pathways induced by sorafenib in myeloma cells: Puma-mediated apoptosis and necroptosis. Clin Transl Oncol 2014 Jul;
    Ram鱈rez-Labrada A et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 191
  • 文献情報:
    Fu DR et al. Prognostic Utility of Apoptosis Index, Ki-67 and Survivin Expression in Dogs with Nasal Carcinoma Treated with Orthovoltage Radiation Therapy. J. Vet. Med. Sci. 2014 Aug;
    Fu DR et al
    2014/01/01
  • 備考:
    Species: Canine, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 192
  • 文献情報:
    Jin B et al. Ponatinib induces apoptosis in imatinib-resistant human mast cells by dephosphorylating mutant D816V KIT and silencing &#x3B2;-catenin signaling. Mol. Cancer Ther. 2014 May;13(5):1217-30
    Jin B et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 193
  • 文献情報:
    Artesi M et al. Connexin 30 expression inhibits growth of human malignant gliomas but protects them against radiation therapy. Neuro-oncology 2014 Aug;
    Artesi M et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 194
  • 文献情報:
    Khan S et al. Early diagnostic value of survivin and its alternative splice variants in breast cancer. BMC Cancer 2014;14:176
    Khan S et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB, IHC-P
  • 参照:
    PubMed
  • No.: 195
  • 文献情報:
    Vogt N et al. No evidence of cell cycle dysregulation in mantle cell lymphoma in vivo. Leuk. Lymphoma 2014 Nov;:1-7
    Vogt N et al
    2014/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 196
  • 文献情報:
    Lu H et al. The Expression and Role of MEKK3 in Renal Clear Cell Carcinoma. Anat Rec (Hoboken) 2014 Nov;
    Lu H et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 197
  • 文献情報:
    Yamazaki H et al. Survivin suppressor (YM155) enhances chemotherapeutic efficacy against canine histiocytic sarcoma in murine transplantation models. Res. Vet. Sci. 2015 Apr;99:137-44
    Yamazaki H et al
    2015/01/01
  • 備考:
    Species: Canine, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 198
  • 文献情報:
    Yi XP et al. Simultaneous silencing of XIAP and survivin causes partial mesenchymal-epithelial transition of human pancreatic cancer cells via the PTEN/PI3K/Akt pathway. Mol Med Rep 2015 Jul;12(1):601-8
    Yi XP et al
    2015/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 199
  • 文献情報:
    Fu DR et al. Prognostic utility of apoptosis index, Ki-67 and survivin expression in dogs with nasal carcinoma treated with orthovoltage radiation therapy. J. Vet. Med. Sci. 2014 Nov;76(11):1505-12
    Fu DR et al
    2014/01/01
  • 備考:
    Applications: IHC
  • 参照:
    PubMed
  • No.: 200
  • 文献情報:
    Galloway NR et al. Yin Yang 1 regulates the transcriptional repression of Survivin. Biochem. Biophys. Res. Commun. 2014 Feb;445(1):208-13
    Galloway NR et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 201
  • 文献情報:
    Kapinas K et al. microRNA-mediated survivin control of pluripotency. J. Cell. Physiol. 2015 Jan;230(1):63-70
    Kapinas K et al
    2015/01/01
  • 備考:
    Species: Human,
  • 参照:
    PubMed
  • No.: 202
  • 文献情報:
    Bongiovanni L et al. Canine cutaneous melanocytic tumours: significance of &#x3B2;-catenin and survivin immunohistochemical expression. Vet. Dermatol. 2015 Aug;26(4):270-e59
    Bongiovanni L et al
    2015/01/01
  • 備考:
    Species: Canine, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 203
  • 文献情報:
    Valenzuela MM et al. Exosomes Secreted from Human Cancer Cell Lines Contain Inhibitors of Apoptosis (IAP). Cancer Microenviron 2015 Aug;8(2):65-73
    Valenzuela MM et al
    2015/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 204
  • 文献情報:
    Wei W et al. Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin. Mol. Cancer 2011;10:16
    Wei W et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 205
  • 文献情報:
    Wei W et al. Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. Mol. Cancer 2009;8:76
    Wei W et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 206
  • 文献情報:
    Stauber RH et al. A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer. Oncotarget 2012 Jan;3(1):31-43
    Stauber RH et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 207
  • 文献情報:
    Campisi G et al. Use of fuzzy neural networks in modeling relationships of HPV infection with apoptotic and proliferation markers in potentially malignant oral lesions. Oral Oncol. 2005 Nov;41(10):994-1004
    Campisi G et al
    2005/01/01
  • 備考:
    Applications: IHC
  • 参照:
    PubMed
  • No.: 208
  • 文献情報:
    Bafford R et al. Angiotensin II and tumor necrosis factor-alpha upregulate survivin and Kruppel-like factor 5 in smooth muscle cells: Potential relevance to vein graft hyperplasia. Surgery 2006 Aug;140(2):289-96
    Bafford R et al
    2006/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 209
  • 文献情報:
    Okada Y et al. A dopamine D4 receptor antagonist attenuates ischemia-induced neuronal cell damage via upregulation of neuronal apoptosis inhibitory protein. J. Cereb. Blood Flow Metab. 2005 Jul;25(7):794-806
    Okada Y et al
    2005/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 210
  • 文献情報:
    Labarrade F et al. Modulating the expression of survivin and other basal epidermal proteins protects human skin from UVB damage and oxidative stress. J Cosmet Dermatol 2015 Sep;14(3):191-203
    Labarrade F et al
    2015/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 211
  • 文献情報:
    Sun B et al. AAG8 promotes carcinogenesis by activating STAT3. Cell. Signal. 2014 Sep;26(9):1863-9
    Sun B et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 212
  • 文献情報:
    Fangusaro JR et al. Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome. Br. J. Cancer 2005 Jan;92(2):359-65
    Fangusaro JR et al
    2005/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 213
  • 文献情報:
    L坦pez-Royuela N et al. Bim is the key mediator of glucocorticoid-induced apoptosis and of its potentiation by rapamycin in human myeloma cells. Biochim. Biophys. Acta 2010 Feb;1803(2):311-22
    L坦pez-Royuela N et al
    2010/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 214
  • 文献情報:
    Engels K et al. Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker. J. Pathol. 2007 Apr;211(5):532-40
    Engels K et al
    2007/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 215
  • 文献情報:
    Lo Muzio L et al. Expression of cell cycle markers and human papillomavirus infection in oral squamous cell carcinoma: use of fuzzy neural networks. Int. J. Cancer 2005 Jul;115(5):717-23
    Lo Muzio L et al
    2005/01/01
  • 備考:
    Applications: IHC
  • 参照:
    PubMed
  • No.: 216
  • 文献情報:
    Yuan J et al. Upregulation of survivin during immortalization of nontransformed human fibroblasts transduced with telomerase reverse transcriptase. Oncogene 2009 Jul;28(29):2678-89
    Yuan J et al
    2009/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 217
  • 文献情報:
    Weber A et al. Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice. Hepatology 2010 Apr;51(4):1226-36
    Weber A et al
    2010/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 218
  • 文献情報:
    Emmanuel C et al. Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis. PLoS ONE 2011;6(3):e17617
    Emmanuel C et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 219
  • 文献情報:
    Stauber RH et al. Nucleocytoplasmic shuttling and the biological activity of mouse survivin are regulated by an active nuclear export signal. Traffic 2006 Nov;7(11):1461-72
    Stauber RH et al
    2006/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 220
  • 文献情報:
    McMurtry MS et al. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J. Clin. Invest. 2005 Jun;115(6):1479-91
    McMurtry MS et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 221
  • 文献情報:
    Yamazaki H et al. Influence of a survivin suppressor YM155 on the chemoresistance of canine histiocytic sarcoma cells. Vet. J. 2015 Sep;205(3):375-80
    Yamazaki H et al
    2015/01/01
  • 備考:
    Species: Canine, Applications: WB
  • 参照:
    PubMed
  • No.: 222
  • 文献情報:
    Tuncel H et al. Nuclear Aurora B and cytoplasmic Survivin expression is involved in lymph node metastasis of colorectal cancer. Oncol Lett 2012 May;3(5):1109-1114
    Tuncel H et al
    2012/01/01
  • 備考:
    Applications: IHC
  • 参照:
    PubMed
  • No.: 223
  • 文献情報:
    Lin CY et al. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan. Oral Oncol. 2005 Jul;41(6):645-54
    Lin CY et al
    2005/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 224
  • 文献情報:
    Sulaiman MK et al. SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas. Mol. Cancer 2015;14:78
    Sulaiman MK et al
    2015/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 225
  • 文献情報:
    Ng L et al. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion. Hepatology 2013 Aug;58(2):667-79
    Ng L et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 226
  • 文献情報:
    Vischioni B et al. Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients. Mol. Cancer Ther. 2006 Nov;5(11):2905-13
    Vischioni B et al
    2006/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 227
  • 文献情報:
    Kim GY et al. Expression of HuR, COX-2, and survivin in lung cancers; cytoplasmic HuR stabilizes cyclooxygenase-2 in squamous cell carcinomas. Mod. Pathol. 2011 Oct;24(10):1336-47
    Kim GY et al
    2011/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 228
  • 文献情報:
    Kunze D et al. Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, Bcl-xL, XIAP and survivin in bladder cancer cells. Int. J. Oncol. 2012 Oct;41(4):1271-7
    Kunze D et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 229
  • 文献情報:
    El-Maarri O et al. Methylation at global LINE-1 repeats in human blood are affected by gender but not by age or natural hormone cycles. PLoS ONE 2011;6(1):e16252
    El-Maarri O et al
    2011/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 230
  • 文献情報:
    Weinman EC et al. Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma. Cancer 2003 May;97(9):2203-11
    Weinman EC et al
    2003/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 231
  • 文献情報:
    Locke FL et al. Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma. J Immunother Cancer 2015;3:20
    Locke FL et al
    2015/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 232
  • 文献情報:
    Mehta A et al. Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid Cancer. Clin. Cancer Res. 2015 Sep;21(18):4123-32
    Mehta A et al
    2015/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 233
  • 文献情報:
    Zhang L et al. Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer. Oncotarget 2015 Apr;6(11):9073-85
    Zhang L et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 234
  • 文献情報:
    Pace E et al. Carbocysteine counteracts the effects of cigarette smoke on cell growth and on the SIRT1/FoxO3 axis in bronchial epithelial cells. Exp. Gerontol. 2016 Aug;81:119-28
    Pace E et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 235
  • 文献情報:
    Lotti R et al. Survivin Modulates Squamous Cell Carcinoma-Derived Stem-Like Cell Proliferation, Viability and Tumor Formation in Vivo. Int J Mol Sci 2016;17(1)
    Lotti R et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 236
  • 文献情報:
    Sadowski SM et al. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis. Oncotarget 2015 Jul;6(20):18038-49
    Sadowski SM et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 237
  • 文献情報:
    Meidhof S et al. ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat. EMBO Mol Med 2015 Jun;7(6):831-47
    Meidhof S et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 238
  • 文献情報:
    Dumont J et al. Formin-2 is required for spindle migration and for the late steps of cytokinesis in mouse oocytes. Dev. Biol. 2007 Jan;301(1):254-65
    Dumont J et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 239
  • 文献情報:
    Qi G et al. Nuclear Survivin expression is correlated with malignant behaviors of head and neck cancer together with Aurora-B. Oral Oncol. 2010 Apr;46(4):263-70
    Qi G et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 240
  • 文献情報:
    Vischioni B et al. Immunohistochemical detection of nuclear survivin in NSCLC: a comparison of commercial antibodies. Histopathology 2007 Apr;50(5):671-5
    Vischioni B et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 241
  • 文献情報:
    Iimori M et al. Phosphorylation of EB2 by Aurora B and CDK1 ensures mitotic progression and genome stability. Nat Commun 2016;7:11117
    Iimori M et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 242
  • 文献情報:
    Allison SJ et al. Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity protein in human cervical cancer cells. Aging (Albany NY) 2009 Mar;1(3):316-27
    Allison SJ et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 243
  • 文献情報:
    Ponnelle T et al. Cellular localisation of survivin: impact on the prognosis in colorectal cancer. J. Cancer Res. Clin. Oncol. 2005 Aug;131(8):504-10
    Ponnelle T et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 244
  • 文献情報:
    Werner TA et al. Survivin and XIAP: two valuable biomarkers in medullary thyroid carcinoma. Br. J. Cancer 2016 Feb;114(4):427-34
    Werner TA et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 245
  • 文献情報:
    Lan L et al. Natural product (-)-gossypol inhibits colon cancer cell growth by targeting RNA-binding protein Musashi-1. Mol Oncol 2015 Aug;9(7):1406-20
    Lan L et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 246
  • 文献情報:
    Mahotka C et al. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas. Int. J. Cancer 2002 Jul;100(1):30-6
    Mahotka C et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 247
  • 文献情報:
    Habtemichael N et al. Expression analysis suggests a potential cytoprotective role of Birc5 in the inner ear. Mol. Cell. Neurosci. 2010 Nov;45(3):297-305
    Habtemichael N et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 248
  • 文献情報:
    Xie D et al. Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma. Br. J. Cancer 2006 Jan;94(1):108-14
    Xie D et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 249
  • 文献情報:
    Wu X et al. Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling. Oncotarget 2016 Mar;7(10):11708-23
    Wu X et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 250
  • 文献情報:
    Scase TJ et al. Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis. J. Vet. Intern. Med. ;20(1):151-8
    Scase TJ et al
  • 備考:
  • 参照:
    PubMed
  • No.: 251
  • 文献情報:
    S旦ling A et al. Autoantibodies to the inhibitor of apoptosis protein survivin in patients with brain tumors. Int. J. Oncol. 2007 Jan;30(1):123-8
    S旦ling A et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 252
  • 文献情報:
    Hayashi N et al. Adenoviral infection of survivin antisense sensitizes prostate cancer cells to etoposide in vivo. Prostate 2005 Sep;65(1):10-9
    Hayashi N et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 253
  • 文献情報:
    Lee S et al. Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. PLoS ONE 2010;5(6):e10995
    Lee S et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 254
  • 文献情報:
    Pizem J et al. Survivin is a negative prognostic marker in medulloblastoma. Neuropathol. Appl. Neurobiol. 2005 Aug;31(4):422-8
    Pizem J et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 255
  • 文献情報:
    Wang H et al. Survivin mRNA-circulating tumor cells are associated with prostate cancer metastasis. Tumour Biol. 2016 Jan;37(1):723-7
    Wang H et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 256
  • 文献情報:
    Zhao Z et al. A role of P301L tau mutant in anti-apoptotic gene expression, cell cycle and apoptosis. Mol. Cell. Neurosci. 2003 Oct;24(2):367-79
    Zhao Z et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 257
  • 文献情報:
    Wang B et al. Expression of NgBR is highly associated with estrogen receptor alpha and survivin in breast cancer. PLoS ONE 2013;8(11):e78083
    Wang B et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 258
  • 文献情報:
    Habtemichael N et al. Cloning and functional characterization of the guinea pig apoptosis inhibitor protein Survivin. Gene 2010 Dec;469(1-2):9-17
    Habtemichael N et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 259
  • 文献情報:
    Wang RH et al. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell 2008 Oct;14(4):312-23
    Wang RH et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 260
  • 文献情報:
    Song J et al. Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion. Immunity 2005 May;22(5):621-31
    Song J et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 261
  • 文献情報:
    Hoffarth S et al. pp32/PHAPI determines the apoptosis response of non-small-cell lung cancer. Cell Death Differ. 2008 Jan;15(1):161-70
    Hoffarth S et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 262
  • 文献情報:
    Lo Muzio L et al. HPV DNA and survivin expression in epithelial oral carcinogenesis: a relationship? Oral Oncol. 2004 Aug;40(7):736-41
    Lo Muzio L et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 263
  • 文献情報:
    Friedman J et al. Neoadjuvant docetaxel and capecitabine in patients with high risk prostate cancer. J. Urol. 2008 Mar;179(3):911-5; discussion 915-6
    Friedman J et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 264
  • 文献情報:
    Jung JE et al. Survivin inhibits anti-growth effect of p53 activated by aurora B. Biochem. Biophys. Res. Commun. 2005 Nov;336(4):1164-71
    Jung JE et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 265
  • 文献情報:
    Fukuda T et al. Putative tumor suppression function of SIRT6 in endometrial cancer. FEBS Lett. 2015 Aug;589(17):2274-81
    Fukuda T et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 266
  • 文献情報:
    Nakata Y et al. Accumulation of &#x3B1;-synuclein triggered by presynaptic dysfunction. J. Neurosci. 2012 Nov;32(48):17186-96
    Nakata Y et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 267
  • 文献情報:
    Papini D et al. TD-60 links RalA GTPase function to the CPC in mitosis. Nat Commun 2015;6:7678
    Papini D et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 268
  • 文献情報:
    Tango Y et al. Detection of autoantibodies against survivin in sera from cancer dogs. J. Vet. Med. Sci. 2010 Jul;72(7):917-20
    Tango Y et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 269
  • 文献情報:
    Peach G. Russia pledges $4 billion for Pharma-2020 plan. Nat. Med. 2011 May;17(5):517
    Peach G
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 270
  • 文献情報:
    Taglieri L et al. Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells. Oncol Lett 2017 Sep;14(3):3832-3838
    Taglieri L et al
    2017/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 271
  • 文献情報:
    Dizdar L et al. Survivin and XIAP expression in distinct tumor compartments of surgically resected gastric cancer: XIAP as a prognostic marker in diffuse and mixed type adenocarcinomas. Oncol Lett 2017 Dec;14(6):6847-6856
    Dizdar L et al
    2017/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 272
  • 文献情報:
    Nonagase Y et al. Heregulin-expressing HER2-positive breast and gastric cancer exhibited heterogeneous susceptibility to the anti-HER2 agents lapatinib, trastuzumab and T-DM1. Oncotarget 2016 Dec;7(51):84860-84871
    Nonagase Y et al
    2016/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 273
  • 文献情報:
    Lettini G et al. TRAP1 regulates stemness through Wnt/&#x3B2;-catenin pathway in human colorectal carcinoma. Cell Death Differ. 2016 11;23(11):1792-1803
    Lettini G et al
    2016/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 274
  • 文献情報:
    Chen B et al. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In&#xA0;Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling. Gastroenterology 2017 06;152(8):
    Chen B et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 275
  • 文献情報:
    Margulis V et al. Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder. J. Urol. 2007 Mar;177(3):1163-8
    Margulis V et al
    2007/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 276
  • 文献情報:
    Gock M et al. Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line. World J. Gastroenterol. 2018 Sep;24(33):3749-3759
    Gock M et al
    2018/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 277
  • 文献情報:
    Lee HS et al. Systematic Analysis of Compounds Specifically Targeting Telomeres and Telomerase for Clinical Implications in Cancer Therapy. Cancer Res. 2018 Nov;78(21):6282-6296
    Lee HS et al
    2018/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 278
  • 文献情報:
    Novais-Cruz M et al. Mitotic progression, arrest, exit or death relies on centromere structural integrity, rather than de novo transcription. Elife 2018 08;7
    Novais-Cruz M et al
    2018/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 279
  • 文献情報:
    Khan S et al. Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in extracellular vesicles (EV) from prostate cancer patients. PLoS ONE 2017;12(10):e0183122
    Khan S et al
    2017/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 280
  • 文献情報:
    Alzoubi S et al. Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer. Oncotarget 2016 Jul;7(28):44505-44521
    Alzoubi S et al
    2016/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 281
  • 文献情報:
    Taglieri L et al. The kinesin Eg5 inhibitor K858 induces apoptosis and reverses the malignant invasive phenotype in human glioblastoma cells. Invest New Drugs 2018 Feb;36(1):28-35
    Taglieri L et al
    2018/01/01
  • 備考:
    Species: Human, Applications:
  • 参照:
    PubMed
  • No.: 282
  • 文献情報:
    Wei Q et al. Synthesis and biological evaluation of novel 2-arylvinyl-substituted naphtho[2,3-d]imidazolium halide derivatives as potent antitumor agents. Eur J Med Chem 2018 Jan;144:504-516
    Wei Q et al
    2018/01/01
  • 備考:
    Species: Human, Applications:
  • 参照:
    PubMed
  • No.: 283
  • 文献情報:
    Troiano G et al. Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma. Int J Mol Sci 2018 Sep;19(9)
    Troiano G et al
    2018/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 284
  • 文献情報:
    Ong SM et al. Anti-tumour efficacy of etoposide alone and in combination with piroxicam against canine osteosarcoma in a xenograft model. Res. Vet. Sci. 2017 Aug;113:130-135
    Ong SM et al
    2017/01/01
  • 備考:
    Species: Canine, Applications: WB
  • 参照:
    PubMed
  • No.: 285
  • 文献情報:
    Tung J et al. A novel 4-arm DNA/RNA Nanoconstruct triggering Rapid Apoptosis of Triple Negative Breast Cancer Cells within 24&#x2009;hours. Sci Rep 2017 04;7(1):793
    Tung J et al
    2017/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 286
  • 文献情報:
    Kiweler N et al. The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells. Arch. Toxicol. 2018 Jul;92(7):2227-2243
    Kiweler N et al
    2018/01/01
  • 備考:
    Species: Mouse, Human, Applications:
  • 参照:
    PubMed
  • No.: 287
  • 文献情報:
    Makii C et al. MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53. Oncotarget 2016 Nov;7(46):75328-75338
    Makii C et al
    2016/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 288
  • 文献情報:
    Liu S et al. Nuclear survivin promoted by acetylation is associated with the aggressive phenotype of oral squamous cell carcinoma. Cell Cycle 2017 May;16(9):894-902
    Liu S et al
    2017/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 289
  • 文献情報:
    Dean EJ et al. A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC. Br. J. Cancer 2010 Jan;102(1):97-103
    Dean EJ et al
    2010/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 290
  • 文献情報:
    Genshaft AS et al. Multiplexed, targeted profiling of single-cell proteomes and transcriptomes in a single reaction. Genome Biol. 2016 Sep;17(1):188
    Genshaft AS et al
    2016/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 291
  • 文献情報:
    Magadum A et al. Live cell screening platform identifies PPAR&#x3B4; as a regulator of cardiomyocyte proliferation and cardiac repair. Cell Res. 2017 Aug;27(8):1002-1019
    Magadum A et al
    2017/01/01
  • 備考:
    Species: Rat, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 292
  • 文献情報:
    Bonora M et al. Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition. Oncogene 2015 Mar;34(12):1608
    Bonora M et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 293
  • 文献情報:
    Kim W et al. Mitochondrial CCAR2/DBC1 is required for cell survival against rotenone-induced mitochondrial stress. Biochem. Biophys. Res. Commun. 2017 Apr;485(4):782-789
    Kim W et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 294
  • 文献情報:
    Scuto A et al. STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphoma. Cancer Res. 2011 May;71(9):3182-8
    Scuto A et al
    2011/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 295
  • 文献情報:
    Christenson JL et al. t-Darpp overexpression in HER2-positive breast cancer confers a survival advantage in lapatinib. Oncotarget 2015 Oct;6(32):33134-45
    Christenson JL et al
    2015/01/01
  • 備考:
    ICC/IF
  • 参照:
    PubMed
  • No.: 296
  • 文献情報:
    Filion TM et al. Survival responses of human embryonic stem cells to DNA damage. J. Cell. Physiol. 2009 Sep;220(3):586-92
    Filion TM et al
    2009/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 297
  • 文献情報:
    Redli PM et al. The Ska complex promotes Aurora B activity to ensure chromosome biorientation. J. Cell Biol. 2016 Oct;215(1):77-93
    Redli PM et al
    2016/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 298
  • 文献情報:
    Wu X et al. Innovative delivery of siRNA to solid tumors by super carbonate apatite. PLoS ONE 2015;10(3):e0116022
    Wu X et al
    2015/01/01
  • 備考:
    Species: Mouse, Applications: WB, ICC/IF
  • 参照:
    PubMed
  • No.: 299
  • 文献情報:
    Liang C et al. A kinase-dependent role for Haspin in antagonizing Wapl and protecting mitotic centromere cohesion. EMBO Rep. 2018 01;19(1):43-56
    Liang C et al
    2018/01/01
  • 備考:
    ICC/IF
  • 参照:
    PubMed
  • No.: 300
  • 文献情報:
    Werner TA et al. Survivin and XIAP - two potential biological targets in follicular thyroid carcinoma. Sci Rep 2017 Sep;7(1):11383
    Werner TA et al
    2017/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 301
  • 文献情報:
    Zhang J et al. Inhibitory effect of the anthelmintic drug pyrvinium pamoate on T315I BCR&#x2011;ABL&#x2011;positive CML cells. Mol Med Rep 2017 Dec;16(6):9217-9223
    Zhang J et al
    2017/01/01
  • 備考:
    Species: Human, Applications:
  • 参照:
    PubMed
  • No.: 302
  • 文献情報:
    Scheer A et al. Survivin expression pattern in the intestine of normoxic and ischemic rats. BMC Gastroenterol 2017 Jun;17(1):76
    Scheer A et al
    2017/01/01
  • 備考:
    Species: Rat, Applications: IHC
  • 参照:
    PubMed
  • No.: 303
  • 文献情報:
    Qi G et al. PARP6 acts as a tumor suppressor via downregulating Survivin expression in colorectal cancer. Oncotarget 2016 Apr;7(14):18812-24
    Qi G et al
    2016/01/01
  • 備考:
    WB
  • 参照:
    PubMed
  • No.: 304
  • 文献情報:
    Tastekin E et al. Prognostic Value of Angiogenesis and Survivin Expression in Patients with Glioblastoma. Turk Neurosurg 2016;26(4):484-90
    Tastekin E et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 305
  • 文献情報:
    Unruhe-Knauf B et al. Analysis of HDACi-Induced Changes in Chromosomal Passenger Complex Localization. Methods Mol. Biol. 2017;1510:47-59
    Unruhe-Knauf B et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 306
  • 文献情報:
    Dheekollu J et al. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency. Oncotarget 2017 Jan;8(5):7248-7264
    Dheekollu J et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 307
  • 文献情報:
    Varughese RK et al. Survivin and gliomas: A literature review. Oncol Lett 2016 Sep;12(3):1679-1686
    Varughese RK et al
    2016/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 308
  • 文献情報:
    Kreger BT et al. The Enrichment of Survivin in Exosomes from Breast Cancer Cells Treated with Paclitaxel Promotes Cell Survival and Chemoresistance. Cancers (Basel) 2016 Dec;8(12)
    Kreger BT et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 309
  • 文献情報:
    Liu T et al. Expression of USP22 and the chromosomal passenger complex is an indicator of malignant progression in oral squamous cell carcinoma. Oncol Lett 2019 Feb;17(2):2040-2046
    Liu T et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 310
  • 文献情報:
    Kubo T et al. Immunohistological analysis of pancreatic carcinoma after vaccination with survivin 2B peptide: Analysis of an autopsy series. Cancer Sci 2019 Aug;110(8):2386-2395
    Kubo T et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 311
  • 文献情報:
    Brown M et al. The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC. PLoS One 2020;15(1):e0226917
    Brown M et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 312
  • 文献情報:
    Wang H et al. Expression of survivin, MUC2 and MUC5 in colorectal cancer and their association with clinicopathological characteristics. Oncol Lett 2017 Jul;14(1):1011-1016
    Wang H et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 313
  • 文献情報:
    Tastekin E et al. Survivin expression, HPV positivity and microvessel density in oropharyngeal carcinomas and relationship with survival time. Arch Med Sci 2017 Oct;13(6):1467-1473
    Tastekin E et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 314
  • 文献情報:
    Erdogan S et al. Neferine inhibits proliferation and migration of human prostate cancer stem cells through p38 MAPK/JNK activation. J Food Biochem 2020 07;44(7):e13253
    Erdogan S et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 315
  • 文献情報:
    Zhou J et al. Salinomycin effectively eliminates cancer stem-like cells and obviates hepatic metastasis in uveal melanoma. Mol Cancer 2019 11;18(1):159
    Zhou J et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 316
  • 文献情報:
    Nourreddine S et al. NF45 and NF90 Regulate Mitotic Gene Expression by Competing with Staufen-Mediated mRNA Decay. Cell Rep 2020 05;31(7):107660
    Nourreddine S et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 317
  • 文献情報:
    Abad MA et al. Borealin-nucleosome interaction secures chromosome association of the chromosomal passenger complex. J Cell Biol 2019 12;218(12):3912-3925
    Abad MA et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 318
  • 文献情報:
    Thamm DH et al. Phase-I trial of survivin inhibition with EZN-3042 in dogs with spontaneous lymphoma. BMC Vet Res 2020 Mar;16(1):97
    Thamm DH et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 319
  • 文献情報:
    Mirshahidi S et al. Inhibitory Effects of Indomethacin in Human MNNG/HOS Osteosarcoma Cell Line <i>In&#xA0;Vitro</i>. Cancer Invest 2020 Jan;38(1):23-36
    Mirshahidi S et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 320
  • 文献情報:
    Liang C et al. Centromere-localized Aurora B kinase is required for the fidelity of chromosome segregation. J. Cell Biol. 2020 Feb;219(2)
    Liang C et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 321
  • 文献情報:
    Rauch A et al. Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells. Oncotarget 2018 Jun;9(45):27835-27850
    Rauch A et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 322
  • 文献情報:
    Ong SM et al. YM155 enhances the cytotoxic activity of etoposide against canine osteosarcoma cells. J Vet Med Sci 2019 Aug;81(8):1182-1190
    Ong SM et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 323
  • 文献情報:
    Bradford EM et al. Epithelial TNF Receptor Signaling Promotes Mucosal Repair in Inflammatory Bowel Disease. J Immunol 2017 09;199(5):1886-1897
    Bradford EM et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 324
  • 文献情報:
    Ferguson Bennit HR et al. Natural Killer Cell Phenotype and Functionality Affected by Exposure to Extracellular Survivin and Lymphoma-Derived Exosomes. Int J Mol Sci 2021 Jan;22(3)
    Ferguson Bennit HR et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 325
  • 文献情報:
    Oliveira ALCSL et al. Maximizing the potency of oxaliplatin coated nanoparticles with folic acid for modulating tumor progression in colorectal cancer. Mater Sci Eng C Mater Biol Appl 2021 Jan;120:111678
    Oliveira ALCSL et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 326
  • 文献情報:
    Dyshlovoy SA et al. Inspired by Sea Urchins: Warburg Effect Mediated Selectivity of Novel Synthetic Non-Glycoside 1,4-Naphthoquinone-6S-Glucose Conjugates in Prostate Cancer. Mar Drugs 2020 May;18(5)
    Dyshlovoy SA et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 327
  • 文献情報:
    Di Vincenzo S et al. Cigarette smoke extract reduces FOXO3a promoting tumor progression and cell migration in lung cancer. Toxicology 2021 04;454:152751
    Di Vincenzo S et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 328
  • 文献情報:
    Murillo-Pineda M et al. Induction of spontaneous human neocentromere formation and long-term maturation. J Cell Biol 2021 03;220(3)
    Murillo-Pineda M et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 329
  • 文献情報:
    Abdo W et al. Protective effect of thymoquinone against lung intoxication induced by malathion inhalation. Sci Rep 2021 01;11(1):2498
    Abdo W et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 330
  • 文献情報:
    Tsunematsu T et al. APC/C<sup>Cdh1</sup> is required for the termination of chromosomal passenger complex activity upon mitotic exit. J Cell Sci 2020 09;133(18)
    Tsunematsu T et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed